REGULATED PRESS RELEASE

from AXA (EPA:CS)

AXA: Half Year Financial Report – June 30, 2024

image

 

 

 

 

Half Year Financial Report

/

 

June 30, 2024

 

 

 

 

 

 

TABLE OF CONTENTS

 

 

 

 

I.      Activity Report……………………………………... 3

 

II.   Consolidated interim financial statements…… 31

 

III.                        Statutory auditors’ review report             on the 2024 Half Year Financial Information …… 85

 

IV.                       Statement of the person responsible for the Half

Year Financial Report …………….…………….. 89

 

 

 

 

                   

GIE_AXA_Internal

 

 

 

 

                                                      I.      Activity Report

 

/

 

June 30, 2024

GIE_AXA_Internal


IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENT REGARDING FORWARDLOOKING STATEMENTS AND THE USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES

Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans, expectations, or objectives. In particular, the statements in the “Outlook” section of this report, including the capital management and distribution policy, is based on the current views and intentions of the Board of Directors and is subject to change. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause AXA’s actual results to differ materially from those expressed or implied in such forward-looking statements. Please refer to Part 5 - “Risk Factors and Risk Management” of AXA’s Universal Registration Document for the year ended December 31, 2023 (the “2023 Universal

Registration Document”) for a description of certain important factors, risks and uncertainties that may affect AXA’s business and/or results of operations. Forward-looking statements in this report speak only as of the date of this report. 

AXA undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events, or circumstances or otherwise, except as required by applicable laws and regulations.

In addition, this report refers to certain non-GAAP financial measures, or alternative performance measures (“APMs”), used by Management in analysing AXA’s operating trends, financial performance and financial position and providing investors with additional information that Management believes to be useful and relevant regarding AXA’s results. These non-GAAP financial measures generally have no standardized meaning and therefore may not be comparable to similarly labelled measures used by other companies. As a result, none of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group’s Consolidated Interim Financial Statements and related notes prepared in accordance with IFRS. Underlying Earnings, Underlying Earnings per Share, Underlying Return on Equity, Combined Ratio and Debt Gearing are APMs as defined in ESMA’s guidelines and the AMF’s related position statement issued in 2015. A reconciliation from APMs Underlying Earnings and Combined Ratio to the most directly reconcilable line item, subtotal, or total in the Consolidated Interim Financial Statements of the corresponding period is provided on pages 18 and 19 of this report. APMs Underlying

Return on Equity and Underlying Earnings per Share are reconciled to the Consolidated Interim Financial

Statements in the tables set forth on page 27 of this report. For further information on any of the above-mentioned APMs, please see the definitions in the section “Alternative Performance Measures” on pages 559 to 560 in the 2023 Universal Registration Document, in its Appendix IV “Glossary”. 

In this report, unless provided otherwise or unless the context otherwise requires, (i) the “Company”, “AXA” and “AXA SA” refer to AXA, a “société anonyme” (a public limited company) organized under the laws of France, which is the publicly traded parent company of the AXA Group, and (ii) the “AXA Group”, the “Group” and “we” refer to AXA SA together with its direct and indirect consolidated subsidiaries. 

This is a translation into English of the Half-Year Financial Report of the Company issued in French and available on the Company’s website (www.axa.com).

Operating Highlights

NEW STRATEGIC PLAN

image

AXA announced its 2024-2026 strategy, setting ambitious new financial targets

On February 22, 2024, AXA published its strategic plan “Unlock the Future” and its key financial targets for 20242026.

The new Plan is focused on growing and strengthening AXA’s core businesses, with continued disciplined execution, following strong delivery of “Driving Progress 2023”(1).

The main financial targets for 2024-2026 are the following:

•       Underlying earnings per share CAGR(2) 2023-2026E between 6% and 8%

•       Underlying return on equity between 14% and 16% over 2024E to 2026E

•       Over Euro 21 billion cumulative organic cash upstream over 2024E to 2026E

•       New capital management policy(3) with a total payout ratio(4) target of 75% of underlying earnings per share, comprising 60% dividend payout ratio and 15% via annual share buy-back(5), and with dividend per share to be at least equal to prior year.

SIGNIFICANT TRANSACTIONS

image

AXA announced an agreement terminating the sale of a closed life and pensions portfolio at AXA

Germany, as well as a reinsurance agreement for an in-force Savings portfolio concluded by AXA Life Europe 

On May 2, 2024, AXA announced that it had mutually agreed with Athora to terminate the sale agreement related to the purchase of a closed life and pensions portfolio from AXA Germany, which was initially communicated on July 14, 2022. AXA will retain this portfolio, which is well capitalized and duration matched, as well as its associated earnings. The termination was expected to have no impact on the financial targets announced by the Group as part of its new strategic plan, “Unlock the Future”.

image 

(1) For additional details, please refer to the AXA Group’s press release “AXA announces its 2024-2026 strategy, setting ambitious new financial targets” published on February 22, 2024 on AXA’s website.

(2) Compounded Annual Growth Rate; period-to-period results may vary.

(3) Subject to annual Board and Shareholders’ Annual General Meeting approvals and absent (1) for share buy-backs, any significant earnings event (i.e., significant deviation in the Group’s underlying earnings) and (2) for dividends, the occurrence of a significant capital event (i.e., event that significantly deteriorates Group solvency). Board discretion includes considering AXA’s earnings, financial condition, applicable capital and solvency requirements, prevailing operating and financial market conditions and the general economic environment.

(4) Payout based on underlying earnings per share.

(5) Annual shares buy-backs exclude share buy-backs related to the neutralization of earnings dilution from disposal and in-force management transactions, as well as the dilutive effect relating to employee share offerings and stock-based compensation.

Separately, AXA Group also announced that its subsidiary AXA Life Europe( 1 ) had entered into a reinsurance agreement(2) with New Reinsurance Company(3) that covers ca. Euro 3 billion of Variable Annuity reserves(4). This transaction will result in a reduction in underlying earnings of ca. Euro 20 million per annum from 2024 onwards. Following the announcement, a Euro 0.2 billion share buy-back was completed to offset the earnings dilution related to the reinsurance agreement. The transaction, including the impact of the share buy-back, was expected to have a ca. -1 point impact on AXA Group’s Solvency II ratio(5).

CAPITAL / DEBT OPERATIONS  

image

AXA announced the successful placement of Euro 1.5 billion Restricted Tier 1 Notes

On January 10, 2024, AXA announced that it had successfully completed the placement with institutional investors of Euro 1.5 billion of Reg S perpetual deeply subordinated notes (the “Notes”) with institutional investors. The Notes qualify as Restricted Tier 1 capital under Solvency II. Investor demand for the issuance was strong with a book subscribed more than 5 times.

The initial fixed rate was set at 6.375% per annum until the end of a 6-month call window period (ending on January

16, 2034), when the interest rate will reset and every five years thereafter at the prevailing Euro 5-year Mid Swap rate plus a margin of 384.1 basis points. In line with the Solvency II requirements, the Notes feature a loss absorption mechanism in the form of a write-down(6) of the nominal amount of the Notes if one of the solvencyrelated triggers(7) is breached(8). Interest payments are at the full discretion of AXA unless they are mandatorily prohibited.

The Notes were rated BBB+ by Standard & Poor’s and Baa1(hyb) by Moody’s. They are eligible to be treated as capital from a regulatory and rating agencies’ perspective within applicable limits.

This issuance was part of AXA Group’s funding plan for 2024 and the proceeds were to be used for general corporate purposes, including the refinancing of part of the AXA Group’s outstanding debt.

The settlement of the Notes took place on January 16, 2024.

Execution of a share repurchase agreement in relation to AXA’s share buy-back program of up to Euro 1.8 billion

On February 23, 2024, AXA entered into a share repurchase agreement with an investment services provider, whereby AXA was initially to buy back its own shares for a maximum amount of Euro 1.6 billion, reflecting:

image 

(1) AXA Life Europe, an Irish entity, manages a portfolio of variable annuity products primarily sold in Germany. It has been closed to new business since 2017.

(2) The reinsurance agreement provides cover for all risks of AXA Life Europe’s portfolio during the accumulation phase, excluding only expenses relating to the management of the portfolio of AXA Life Europe. Longevity risk during the decumulation phase is excluded from the scope of this agreement.

(3) New Reinsurance Company Ltd, a Swiss entity, is a subsidiary of Munich Re and a member of the Munich Re Group.

(4) Amount as of full year 2023.

(5) As of half year 2024.

(6) With discretionary reinstatement subject to conditions as further described in the Prospectus dated January 10, 2024.

(7) As determined under Solvency II.

(8) Either at AXA Group level or at AXA SA solo level. AXA SA expects to transition the calculation of its Solo Solvency II ratio from the Solvency II standard formula to the AXA Group’s Internal Model by the end of 2024, subject to prior approval by the ACPR. At AXA SA level, the impact of such transition is expected to result in a reduction in the AXA SA Solo Solvency II ratio to a level more consistent with AXA Group’s Solvency II ratio. At Group level, such transition is expected to have an immaterial impact on the AXA Group’s Solvency II ratio and a limited negative impact on the AXA Group’s MCR coverage. The AXA SA MCR coverage is expected to remain materially above the AXA Group MCR coverage.

•       Euro 1.1 billion share buy-back, in line with its new capital management policy, as announced on February 22, 2024

•       Euro 0.5 billion anti-dilutive share buy-back related to the reinsurance agreement for an in-force Savings portfolio at AXA France, as announced on December 20, 2023

Under the initial share repurchase agreement(1) signed on February 23, 2024, shares were bought back commencing on February 26, 2024, and the execution of the share buy-back was expected to end at the latest on August 5, 2024.

On May 7, 2024, AXA announced an amendment to the initial share repurchase agreement with the investment services provider, to increase by Euro 0.2 billion to Euro 1.8 billion the maximum amount of its own shares that AXA would buy back. The amendment also extended the end of the purchase period from August 5 to August 30, 2024. This amendment reflected the Euro 0.2 billion anti-dilutive share buy-back program relating to the execution of the reinsurance agreement between AXA Life Europe and New Reinsurance Company, as announced on May 2, 2024.

The share buy-back program, as amended, was completed on June 13, 2024, for an amount of Euro 1.8 billion(2), having been carried out in accordance with the terms of the applicable Shareholders’ Annual General Meeting authorization(3). On each day during the purchase period, the price per share paid by AXA(4) was determined based on the volume-weighted average share price.

AXA intends to cancel all shares repurchased pursuant to this share buy-back program.

AXA announced cash tender offers for two series of subordinated notes

On February 26, 2024, AXA announced an all-cash tender offer for each of the following two series of AXA SA subordinated notes:

•       GBP 350,000,000 Fixed to Floating Rate Undated Deeply Subordinated Notes issued on July 6, 2006(5) and

•       GBP 723,925,000 Undated Deeply Subordinated Resettable Notes issued on November 7, 2014(6)

The tender offers expired at 5:00 p.m., Central European time, on March 4, 2024. 91% of the GBP 350,000,000 Fixed to Floating Rate Undated Deeply Subordinated Notes issued on July 6, 2006 were tendered, as were 95% of the GBP 723,925,000 Undated Deeply Subordinated Resettable Notes issued on November 7, 2014.

The transaction was part of AXA Group’s active management of its debt structure and will allow AXA to further optimize its capital base.

AXA announced the placement of Euro 750 million senior notes due 2034

On May 29, 2024, AXA announced the placement of Euro 750 million of Reg S senior unsecured notes due 2034 (the “Notes”) with institutional investors. The settlement of the Notes took place on May 31, 2024.

The Notes have a fixed annual coupon of 3.375% and were rated A+ by Standard & Poor’s and A1 by Moody’s.

image 

(1) On February 23, 2024, it was indicated that the up to Euro 1.6 billion share buy-back program would be executed in addition to any other potential anti-dilutive share buy-back.

(2) AXA bought back its own shares for an exact amount of Euro 1,799,999,979.81.

(3) The Shareholders’ Annual General Meeting authorization granted on April 27, 2023, or on April 23, 2024, as applicable.

(4) The purchase price did not exceed the maximum purchase price approved at the applicable Shareholders’ Annual General Meeting.

(5) Fixed rate of 6.6862% until the first call date on July 6, 2026.

(6) Fixed rate of 5.453% until the first call date on March 4, 2026.

This issuance was part of AXA Group’s funding plan for 2024 and the proceeds were to be used for general corporate purposes, including the refinancing of part of the AXA Group’s outstanding debt. Over the period 2024 to 2026, the Group intends to maintain a stable debt stock(1).

PARTNERSHIPS AND INNOVATION

image

The Universal Postal Union (UPU) and AXA join forces to advance inclusive insurance through Postal Networks

Postal networks play a crucial role in global financial inclusion, with over a quarter of the world’s adult population accessing formal financial services through their post office. This is possible because postal networks combine lastmile distribution reach with strong customer trust, thereby reaching very remote populations most other networks do not extend to, including those working in the informal economy. Posts have traditionally focused on payments and savings, and today insurance is generating a growing interest and shows great promise. In 2021, 53% of posts offered insurance, up from 38% in 2016(2).

Through AXA EssentiALL, the Group’s inclusive insurance business, AXA provides affordable, accessible, and attractive insurance solutions to over 14 million people and micro-businesses(3) by leveraging physical and digital distribution channels that target these lower income classes, have scaled and penetrated networks, as well as trusted brand names. Initially focused on emerging markets, AXA EssentiALL is extending its geographical scope to Europe to bring inclusive insurance solutions to low to middle income households and small businesses facing purchasing power and social protection challenges.

This two-phased partnership between UPU and AXA began in Q2 2024 with a research program showcasing successful postal insurance models around the world to provide posts and insurers with insights and best practices.

Building on this research and its actionable conclusions, UPU and AXA will work together to establish the Postal Insurance Technical Assistance Facility (PITAF). PITAF will aim to provide local posts with both technical and financial support to avail, expand or diversify inclusive insurance schemes. Capitalizing on the UPU’s postal network and AXA’s insurance expertise, PITAF will help promote financial inclusion and risk mitigation amongst underserved populations.

GOVERNANCE

image

Composition of the Board of Directors and its Committees

The Shareholders’ Meeting of April 23, 2024, approved (i) the renewal of the terms of office for Antoine Gosset-

Grainville, Clotilde Delbos, and Isabel Hudson as directors (for 4 years), as well as for Angelien Kemna and MarieFrance Tschudin (for 3 years), and (ii) the appointment as director, upon the proposal of the AXA Group's employee shareholders, of Helen Browne (for 4 years).

André François-Poncet, whose term of office expired at the end of the Shareholders’ Meeting, did not wish to stand for re-election and has not been replaced. 

image 

(1) Please refer to the AXA Group’s press release “AXA announces its 2024-2026 strategy, setting ambitious new financial targets” published on February 22, 2024 on AXA’s website. 

(2) “Advancing financial inclusion through access to insurance: the role of postal networks”, Universal Postal Union – International Labor Organization, 2016.

(3) AXA Group, full year results 2023.

The Board of Directors is therefore comprised of 15 members, including 9 women and 6 men. In addition, 9 directors are considered independent (representing 75%, in accordance with the Afep-Medef Code). 

In addition, the Board of Directors, which met after the Shareholders’ Meeting, confirmed the renewal of Antoine Gosset-Grainville’s term as Chairman of the Board of Directors for the duration of his directorship, and appointed Clotilde Delbos as a member of the Finance & Risk Committee.

On August 1, 2024, the Board of Directors decided to appoint Gérald Harlin as a member of the Compensation, Governance & Sustainability Committee.

The composition of the Board Committees is now as follows:

•       Audit Committee: Isabel Hudson (Chairwoman), Clotilde Delbos, Ramon Fernandez, Angelien Kemna and Rachel Picard;

•       Finance & Risk Committee: Ramon Fernandez (Chairman), Clotilde Delbos, Gérald Harlin, Isabel Hudson and Ramon de Oliveira;

•       Compensation, Governance & Sustainability Committee: Guillaume Faury (Chairman), Bettina Cramm (employee representative), Rachel Duan, Gérald Harlin and Marie-France Tschudin.

Furthermore, Rachel Duan informed the Board of Directors of her intention to resign her directorship at the end of the year.

OTHER

image

AXA published the fourth edition of its Mind Health Report

On March 6, 2024, AXA published the fourth edition of its Mind Health Report, a study aimed at identifying mental health and well-being problems in society in order to build solutions to alleviate them. This was carried out jointly with Ipsos among 16,000 people aged 18 to 75 from sixteen European, Asian and American countries and territories.

In this fourth edition, AXA and Ipsos focused specifically on understanding the working population’s mental health and wellbeing. It reveals that 3 in 4 people are experiencing multiple mental health conditions as a result of their work environment, of whom almost 70% feel disengaged with work.

The work environment seems to take the greatest toll on the mental health of younger populations. Whilst almost a quarter (23%) of all workers have been signed off work on sick leave due to mental health issues, this figure rises to 38% amongst young workers. Almost two-thirds (62%) of those aged between 18-44 responded that mental health care and support provided by their employers is important in their decision to remain at their places of work.

The economic impact is clear. For countries and territories included in our study, the cost of mind health at work is estimated at 2.7 trillion dollars, on average 4.4% of their GDP(1).

Mental health conditions are, in large part, preventable with accessible and comprehensive support. More than 50% responded that company-driven mental health initiatives and benefits, such as firmwide mental health first aid courses, would influence their engagement at work.

Today, only 4 out 10 people would seek professional help if work affected their mental wellbeing. Almost 70% believe that they could reach out to family, friends, or peers if they needed the psychological support. For example, AXA France built an internal network of 100 employees to act as mental health first-aid respondents towards peers.

image 

(1) Cebr was commissioned by AXA to estimate the impact of workers' disengagement from work / decreased productivity due to the health consequences of work-related stress on the economy of 16 countries and territories.

AXA trains its individual shareholders on the challenges of climate change 

On April 4, 2024, AXA announced the roll-out of its training offer on the challenges of climate change to its individual shareholders, thus confirming its ambition to be a responsible player in society in the face of environmental challenges.

The fight against climate change, as well as prevention and adaptation to this change, are strategic pillars for AXA, as an insurer, as an investor and as an employer. This is why, after having trained 96% of its employees in the challenges of climate change through a training program created by AXA Climate, the Group is now going to offer this training, The Climate School, to its individual shareholders.

AXA Climate's Climate School has been produced with contributions from over 120 scientists, experts and researchers around the world and is the most comprehensive 100% digital micro-learning catalogue on environmental and sustainable transition issues to date. It provides a user-friendly, science-based learning experience to explain the impacts of climate change on the environment and businesses, and to show what can be done to reduce them at both individual and corporate level. It is, for example, through this platform and its various modules that we aim to reinforce the awareness of our individual shareholders about these issues.

RISK FACTORS

image

The principal risks and uncertainties faced by the Group are described in detail in Section 5.1 “Risk Factors” and Section 7.3 “General Information” of the 2023 Universal Registration Document (on pages 236 to 257 and pages 486 to 505, respectively). The 2023 Universal Registration Document was filed with the Autorité des marchés financiers (the “AMF”) on March 18, 2024, and is available on the AMF’s website (www.amf-france.org) as well as on AXA's website (www.axa.com). The descriptions contained in these sections of the 2023 Universal Registration Document remain valid in all material respects at the date of the publication of this report regarding the evaluation of the major risks and uncertainties affecting the Group as of June 30, 2024, or which Management expects could affect the Group during the remainder of 2024. 

RELATED PARTY TRANSACTIONS 

image

During the first half of 2024, there were (i) no modifications to the related-party transactions described in Note 25

“Related-party transactions” to the audited Consolidated Financial Statements for the fiscal year ended December 31, 2023, included in the 2023 Universal Registration Document (pages 460 and 461) filed with the AMF and available on its website (www.amf-france.org) as well as on the Company's website (www.axa.com), which significantly influenced the financial position or the results of the Company during the first six months of the fiscal year 2024, and (ii) no new transactions concluded between AXA SA and related parties that significantly influenced the financial position or the results of the Company during the first six months of 2024.

             

Events subsequent to June 30, 2024

AXA entered into an exclusive negotiation to sell AXA Investment Managers to BNP Paribas On August 1, 2024, AXA announced that it has entered into an exclusive negotiation to sell its asset manager AXA

Investment Managers (“AXA IM”) to BNP Paribas for cash proceeds(1) of €5.1 billion. In addition, AXA would receive €0.3 billion consideration from the sale of Select(2) to AXA IM prior to the closing of the proposed transaction. The total estimated transaction value is expected to be €5.4 billion, representing a multiple of 15x 2023 earnings. Under the terms of the proposed transaction, AXA and BNP Paribas would also enter into a long-term strategic partnership under which BNP Paribas would provide investment management services to AXA. The combination of AXA Investment Managers and BNP Paribas would create a leading European asset manager, with total assets under management of €1.5 trillion(3)

The intention to exit the Asset Management business further emphasizes the Group’s strategy to simplify its business model and to focus on its core insurance activities. In particular, AXA’s Life & Savings business is wellpositioned to grow, driven by the Group’s strong distribution and product design capabilities, and our customers will benefit from a broader array of asset classes, including continued access to a best-in-class Alternatives asset management platform. AXA retains full authority over product design, asset allocation and asset-liability management decisions. 

The completion of the transaction is subject to customary closing conditions, including the information and consultation of employee representative bodies, followed by the signing of the Share Purchase Agreement and the receipt of regulatory approvals, and is expected to be finalized by the second quarter of 2025. 

Starting from FY24, AXA IM will be classified as ‘discontinued operations’ in AXA’s consolidated financial statements and AXA will continue to account for the contribution of AXA IM to the Group’s Underlying Earnings until the expected completion of the sale. Upon completion, the proposed transaction is expected to result in (i) a reduction in Underlying Earnings of ca. Euro 0.4 billion on an annualized basis for the Group and (ii) an estimated one-off Net Income gain of €2.2 billion. AXA intends to offset the earnings dilution from the proposed disposal with a share buyback, currently estimated at Euro 3.8 billion, to be launched immediately following the closing of the proposed transaction. The proposed transaction and the associated share buyback are expected to have a neutral impact on AXA’s Solvency II ratio. The proposed transaction is expected to have no material impact on the key financial targets(4 that were communicated as part of the ‘Unlock the Future’ plan.

           

image 

(1) For 100% share capital of AXA IM, of which 98% is owned by the AXA Group (67% by AXA SA and 31% by other AXA entities), subject to price adjustment mechanisms.

(2) Select (formerly named ‘Architas’) is an AXA company offering investment solutions, including management of funds, investment management services, advisory services and investment related services, to retail customers in France, Belgium, Hong Kong and Indonesia.

(3) As of December 31st, 2023, based on companies’ financial disclosures.

(4) Underlying earnings per share CAGR 2023-2026E between 6% and 8%, Underlying return on equity between 14% and 16% over 2024E to 2026E, over Euro 21 billion cumulative organic cash upstream over 2024E to 2026E.

Market Environment

FINANCIAL MARKET CONDITIONS

STOCK MARKETS

image

(main indices, in pts)

June 30, 2024

June 30, 2024 / December 31, 2023

June 30, 2023

June 30, 2023 /  December 31, 2022

CAC 40

7,479

4,894

-1%

8%

7,400

4,399

14%

16%

Eurostoxx 50

FTSE 100

8,164

6%

7,532

1%

Nikkei

39,583

18%

33,189

27%

S&P 500

5,460

14%

4,450

16%

MSCI World

3,512

11%

2,967

14%

MSCI Emerging

1,086

6%

989

3%

                 

Source: Bloomberg.                                                                                                        

Over the first half of 2024, stock markets continued to build on the momentum of 2023, anticipating lower inflation and, therefore, first cuts in interest rates from central banks. The MSCI AC World index increased by 11% across the first half of 2024.

In the United States, the S&P 500 followed on from strong gains in 2023 to deliver an equally solid first half of 2024, up 14% from end-2023. Performance again had a narrow base, with gains concentrated in technology companies. 

In Europe, markets have also performed well, although they have not matched gains observed in the United States. The Euro Stoxx 50 index rose by 8% in the first half of the year. This pattern was broadly echoed across the Eurozone economies. However, the French CAC 40 has fallen by 1% so far this year, with most of this underperformance materializing in June as President Macron announced snap elections that introduced political uncertainty. In the United Kingdom, the FTSE 100 has continued to underperform most markets in the first half of 2024 (+6%). 

In Asia, Japan’s stock markets also performed strongly, boosted by the sharp depreciation of the Yen boosting overseas sales and the yen value of overseas profits. The Nikkei rose by 18% in the first half of 2024. 

             

BOND MARKETS

image

(Government bonds in % or basis points (bps))

June 30, 2024

June 30, 2024 /  December 31, 2023

June 30, 2023

June 30, 2023 /  December 31, 2022

10Y French bond

3.30%

2.50%

+74 bps

+48 bps

2.93%

2.39%

 -19 bps

 -18 bps

10Y German bond

10Y Swiss bond

0.60%

-10 bps

0.96%

 -66 bps

10Y Italian bond

4.07%

+37 bps

4.07%

 -64 bps

10Y UK bond

4.17%

+64 bps

4.39%

+72 bps

10Y Japanese bond

1.06%

+44 bps

0.40%

 -2 bps

10Y US bond

4.40%

+52 bps

3.84%

 -4 bps

Source: Bloomberg.                                                                                                                                                

The bond markets have seen a general rise in yields over the first half of 2024, signalling a shift in market expectations since the end of 2023.

In the United States, market expectations of seven cuts at the end of 2023 for the Federal Reserve have shifted to a view of one or two cuts by year-end 2024. As a result, US 10-year Treasury yields have risen by 52bps to close the first half of 2024 at 4.40%.

In Europe, the Central Bank also saw a shift in outlook, with markets currently expecting three cuts for the year, down from seven at the end of 2023. German bund 10-year yields were 48bps higher (at 2.50%), Italian BTP 10-year yields were 37bps higher (4.07%), and Spanish 10-year bonds were 43bps higher (3.42%). France stands out with OAT 10-year yields rising by 74bps (3.30%), with 20bps of that underperformance occurring over May and June, reflecting public deficit concerns exacerbated by recent political uncertainty. UK 10-year Gilt yield rose by 64bps (4.17%).

In Japan, the surge in global inflation has impacted the Japanese economy and the Bank of Japan tightened its monetary policy in March. Accordingly, 10-year bond yields rose by 44bps in the first half of 2024 to 1.06% - their highest in 12 years.

Corporate spreads have continued to tighten this year across jurisdictions and credit quality. In the United States, spreads have pulled to their tightest levels since pre-2007, close to the pre-pandemic tights. European credit spreads have also narrowed sharply this year following a less aggressive correction last year.

             

EXCHANGE RATES

image

                                                                                 End of Period Exchange rate                                 Average Exchange rate

(for €1)

June 30, 2024

June 30, 2024 / December 31, 2023

June 30, 2024

June 30, 2024 / June 30, 2023

US Dollar 

1.07 

0.85 

-3%

-2%

1.08 

0.85 

0% -2%

British Pound Sterling 

Swiss Franc 

Japanese Yen 

0.96 

172 

4%

0.96 

165 

-2%

13%

11%

Source : WM/Refinitiv                                                                                                                       

Exchange rates in developed markets have been relatively stable in the first half of 2024 as adjustments in interest rate outlooks have been similar across jurisdictions. The one notable exception is the Japanese Yen that weakened significantly as the Bank of Japan continued to maintain low interest rates in a bid to revive inflation on a sustainable basis.

The Euro closed 2023 at a strong USD 1.10, up 3% over the year. It has retraced most of this, back to USD 1.07 over the first half of the year, though nearly half of the move so far this year occurred in June and is associated with political uncertainty, notably in France. The British Pound Sterling has made steady gains against the Euro, up 2% this year to GBP 0.85. The Japanese Yen has seen the sharpest moves, dropping by 11% versus the Euro to JPY 172 in the first half of this year.

Activity and Earnings Indicators

ACTIVITY INDICATORS 

image

(in Euro million, except percentages)

June 30, 2024

June 30, 2023

June 30, 2024 / 

June 30, 2023

(a)

Gross Written Premiums & Other Revenues (b)

59,872 32,522

26,505

55,740

7.0%

Property & Casualty

30,400

24,528

6.7%

7.4%

Life & Health

       o/w Life

17,419

16,297

7.5%

       o/w Health

9,086

8,231

7.4%

Asset Management

787

749

5.1%

Banking

57

1,206

62

-8.2%

New Business Value (NBV) (1)

1,179

5.8%

Present Value of Expected Premiums (PVEP) (2)

25,588 4.7%

23,260

12.5%

NBV Margin (1)/(2)

5.1%

-0.3 pt

imageAverage Assets under Management(c ) 749 736 1.8% (a) Changes are on comparable basis.    (b) Net of Intercompany eliminations.    

(c) in Euro billion.                                                                                                                                                            

(in Euro million, except percentages)

June 30, 2024

June 30, 2023

June 30, 2024 / 

June 30, 2023

(a)

Gross Written Premiums & Other Revenues (b)

59,872 14,719 22,579

55,740

7.0%

France

13,859 20,996

4.7%

5.4%

Europe

AXA XL

11,220

10,534

7.4%

Asia, Africa & EME-LATAM

9,571

8,610

15.3%

AXA IM

787

749

5.1%

Transversal & Central Holdings

995

993

-0.6%

(a) Changes are on comparable basis.    (b) Net of Intercompany eliminations.    

Consolidated Gross Written Premiums and Other Revenues amounted to €59,872 million as of June 30, 2024, up 7.4% on a reported basis, and up 7.0% on a comparable basis compared to June 30, 2023. 

The comparable basis restatement (€-0.2 billion or -0.4 point) mainly includes the half-year 2023 contribution of acquired entities in Spain, Türkiye and United Kingdom & Ireland. It also neutralizes the foreign exchange rate movements due to the appreciation of the average Euro exchange rate, mainly against the Japanese Yen, partly offset by the depreciation notably against the Swiss Franc.  

GROSS WRITTEN PREMIUMS & OTHER REVENUES

image

Property & Casualty gross written premiums were up 7% (or €+2,048 million) on a comparable basis to €32,522 million:  

•       Commercial lines grew by 7% (or €+1,323 million) primarily driven by (i) AXA XL Insurance (+7%) mainly from strong price increases across all lines except US Professional and Cyber, along with volume growth and strong retention mostly driven by Property, Casualty as well as the renewal of a multi-year fronting deal, (ii) Asia, Africa & EME-LATAM (+23%) mainly driven by Türkiye mostly from higher average premiums in Property and Motor in a hyperinflationary context, along with favorable volume and price effects most notably in Mexico and Colombia, (iii) Europe (+5%) from price increases in all lines of business, notably Property and Motor, combined with a positive volume effect, (iv) France (+5%) reflecting price increases, notably in Property and Motor;

•       Personal lines grew by 6% (or €+555 million) driven by (i) Non-Motor (+8%) primarily in Europe (+7%) mostly in Germany, Switzerland and United Kingdom & Ireland from strong price increases, partly offset by lower volumes with focus on profitability, in Asia, Africa & EMEA-LATAM (+35%) notably in Colombia from higher volumes and price effect in Compulsory accident insurance, and Türkiye from higher average premiums in Property, and finally in France (+5%) stemming from price increases. Gross written premiums also grew in (ii) Motor (+4%), in particular in France (+11%) from strong price increases combined with new business growth, in Europe (+2%) driven by strong price effects, partly offset by lower volumes and a change in business mix notably as a result of underwriting measures in United Kingdom & Ireland as well as in Germany, and finally in Asia, Africa & EME-LATAM (+5%) mainly driven by Türkiye mostly from higher average premiums in a hyperinflationary context, along with favorable volume and price effects, notably in Mexico;

•       AXA XL Reinsurance increased by 10% (or €+170 million) primarily from price increases in Property and in Casualty, as well as higher volumes in Specialty.

Life & Health gross written premiums were up 7% (or €+1,856 million) on a comparable basis to €26,505 million.

Life gross written premiums were up 7% (or €+1,230 million) on a comparable basis to €17,419 million: 

•       General Account Savings increased by 12% (or €+581 million) mainly driven by (i) Asia, Africa & EMELATAM (+90%) reflecting the strong increase in sales of the capital-light Single Premium Whole Life product in Japan following the improved performance of broker channels, and (ii) Europe (+8%) notably from the successful launch of capital-light products in Italy and Belgium;

•       Unit-Linked increased by 11% (or €+410 million) driven by (i) Europe (+22%) primarily from the launch of a new product in Italy, as well as (ii) in France (+5%) from successful commercial campaigns in Individual savings;

•       Protection grew by 3% (or €+240 million) mainly from (i) Protection with Unit-Linked (+21%) in Asia, Africa & EME-LATAM (+21%) driven by continued growth in Japan, and (ii) Pure Protection (+1%) mainly in Hong Kong. 

Health gross written premiums were up 7% (or €+626 million) on a comparable basis to €9,086 million: 

•       Group business increased by 10% (or €+392 million), driven by strong tariff increases and higher volumes mostly in France (+7%), in Asia, Africa & EME-LATAM (+24%) mainly in Mexico and Hong Kong, and in Europe (+11%) notably in United Kingdom & Ireland;

•       Individual business grew by 5% (or €+234 million), primarily from tariff increases, driven by Asia, Africa & EME-LATAM (+9%) mostly in Türkiye and Mexico, and in France (+15%).

Asset Management revenues were up 5% (or €+38 million) on a comparable basis to €787 million mainly driven by higher management fees (€+24 million) from higher Average Assets under Management and higher performance fees (€+16 million).

Average Assets under Management increased by 2% (or €+13 billion) on a comparable basis to €749 billion mainly driven by favorable market effects, combined with business growth in both AXA IM Alts and Core activities.

Banking revenues decreased by 8% (or €-5 million) on a comparable basis to €57 million mainly due to pressure on margins in the context of higher interest rates.

NEW BUSINESS PERFORMANCE

image

Present Value of Expected Premiums (“PVEP”)

PVEP increased by 10% on a reported basis and 12% on a comparable basis to €25,588 million driven by (i) Life (+8%), from higher volumes in Japan and France, and (ii) Health (+27%), mainly from France due to higher volumes and favorable changes in actuarial assumptions.

New Business Value Margin (“NBV margin”)

NBV margin decreased by 0.4 point on a reported basis and 0.3 point on a comparable basis to 4.7% mainly driven by a less favorable business mix in Japan.

 


UNDERLYING EARNINGS AND NET INCOME GROUP SHARE

JUNE 30, 2024

image

(in Euro million, except percentages)

June 30, 2024

France

Europe

AXA XL

Asia, Africa & EMELATAM

AXA IM

Transversal & Central Holdings 

Short-term Business

 

35,273

 

 

 

 

 

 

Revenues

9,046

11,839

9,022

4,312

image

1,053

Combined Ratio                                                                                      image

Technical Margin

2,877

692

998

1,111

70

image

6

Long-term Business

 

1,395

 

 

 

 

 

 

CSM Release

407

468

4

516

image

0

Technical Experience

-64

-40

-11

3

-17

image

0

Financial Results & Other

 

2,064

 

 

 

 

 

 

Financial Results

350

784

283

382

24

241

Other Revenues

1,459

53

-18

0

0

937

488

Other Expenses

-1,624

-83

-10

0

-9

-698

-823

Debt Financing Charges

-471

0

-1

-16

-7

0

-447

Underlying Earnings Before Tax

5,638

-1,427

1,380

2,210

1,385

935

263

-535

Income Tax 

-350

-536

-355

-205

-69

88

Minority interests, Income from Affiliates & Other

33

4

-49

0

68

10

0

UNDERLYING EARNINGS GROUP SHARE

4,244

1,034

1,626

1,030

798

204

-447

                                                                                                                                                                         

Net Realized Capital Gains & Losses

93

image

Fair Value of Funds & Derivatives

-43

image

Amortization of Intangibles

-50

image

Integration and Restructuring costs 

-78

image

Exceptional Items

-147

image

NET INCOME GROUP SHARE

4,020

image

Property & Casualty Combined Ratio

90.2%

87.8%

90.3%

87.7%

98.0%

image

100.1%

Life & Health Short-Term Combined Ratio

97.6%

96.7%

98.8%

image

99.1%

image

92.2%

JUNE 30, 2023

                                                                               June 30,             Property &                                                                  Asset

(in Euro million)                                                                                                2023               Casualty                     Life & Health                Management                 Holdings(a)

Short-term Business

 

 

 

 

 

Revenues

32,396

25,254

7,142

Combined Ratio

90.9%

98.9%

Technical Margin

2,368

2,288

80

Long-term Business

 

 

 

 

 

CSM Release

1,474

1,474

Technical Experience

-41

-41

Financial Results & Other

 

 

 

 

 

Financial Results Other Revenues

1,804

1,397

1,193

431

15

909

166

489

Other Expenses

Debt Financing Charges

-1,449 -461

-682

-766

-461

Underlying Earnings Before Tax

5,092

3,480

1,944

241

-574

Income Tax 

-1,072

-761

-381

-66

136

Minority interests, Income from Affiliates & Other

92

-2

81

13

0

UNDERLYING EARNINGS GROUP SHARE

4,111

2,717

1,643

188

-437

 

 

 

 

 

 

Contractual Service Margin stock (b)

34,328

212

34,116

 

 

(a) Holdings segment includes banking and holding activities.

(b) Life & Health Contractual Service Margin is restated following the termination in 2024 of the sale agreement of a closed life and pensions portfolio at AXA Germany, classified as held for sale as of June 30, 2023.

(in Euro million, except percentages)

June 30,  2023

France

Europe

AXA XL

Asia, Africa & EMELATAM

AXA IM

Transversal & Central Holdings 

Short-term Business

 

 

 

 

 

 

 

Revenues

32,396

8,432

10,685

8,670

3,602

image

1,008

Combined Ratio Technical Margin

image

2,368

image

516

image

823

image

953

image

77

image

image

-2

Long-term Business

 

 

 

 

 

 

 

CSM Release

1,474

433

487

1

553

image

0

Technical Experience

-41

-39

5

0

-6

image

0

Financial Results & Other

 

 

 

 

 

 

 

Financial Results

1,804

357

738

239

266

15

190

Other Revenues

1,397

58

1

0

0

909

429

Other Expenses

-1,449

-83

19

0

-9

-682

-693

Debt Financing Charges

-461

0

-1

-18

-8

0

-434

Underlying Earnings Before Tax

5,092

1,241

2,071

1,175

873

241

-511

Income Tax 

-1,072

-222

-470

-237

-190

-66

113

Minority interests, Income from Affiliates & Other

92

6

-56

0

129

13

0

UNDERLYING EARNINGS GROUP SHARE

4,111

1,025

1,545

938

813

188

-398

Net Realized Capital Gains & Losses

-30

image

image

image

image

image

image

Fair Value of Funds & Derivatives

-74

image

image

image

image

image

image

Amortization of Intangibles

-93

image

image

image

image

image

image

Integration and Restructuring costs 

-82

image

image

image

image

image

image

Exceptional Items

1

image

image

image

image

image

image

NET INCOME GROUP SHARE

3,833

image

image

image

image

image

image

Property & Casualty Combined Ratio

90.9%

90.7%

90.1%

89.0%

97.9%

image

100.4%

Life & Health Short-Term Combined Ratio

98.9%

96.8%

106.1%

image

97.8%

image

98.9%

Alternative Performance Measures

Underlying Earnings, Underlying Earnings per Share, Combined Ratio, Underlying Return on Equity and Debt Gearing are Alternative Performance Measures (“APMs”) as defined in ESMA’s guidelines and the AMF’s related position statement issued in 2015. A reconciliation from Underlying Earnings and Combined Ratio to the most directly reconcilable line item, subtotal, or total in the Consolidated Financial Statements of the corresponding period is provided in the above tables. Underlying Return on Equity and Underlying Earnings per Share are reconciled to the Consolidated Financial Statements in the table set forth on page 27 of this report. For further information on any of the above-mentioned APMs, please see the definitions in the section “Alternative Performance Measures” on pages 559 to 560 of the 2023 Universal Registration Document, in its Appendix IV “Glossary”.

Commentary on Group Earnings

UNDERLYING EARNINGS

image

On a reported basis, Underlying Earnings amounted to €4,244 million, up €133 million (+3%).

On a constant exchange rate basis, Underlying Earnings increased by €158 million (+4%), with growth from Property & Casualty (€+185 million or +7%), Life & Health (€+111 million or +7%, increasing to €+134 million or

+8% when excluding the impact of the reinsurance agreements on in-force portfolios in France and AXA Life Europe, as well as the acquisition of Laya in Ireland) and Asset Management (€+16 million or +8%), partly offset by Holdings (€-154 million).       

PROPERTY & CASUALTY

(in Euro million, except percentages)

June 30,

2024

 

Commercial

lines

 

Personal lines

 

AXA XL

Reinsurance

 

Intercompany eliminations 

 

Short-term Business

 

 

 

 

 

Revenues

27,294

18,657

9,144

1,155

-1,662

Combined Ratio

90.2%

90.1%

92.9%

78.7%

image

Technical Margin

2,682

1,850

645

246

-60

Financial Results & Other

1,324

993

240

119

-28

Underlying Earnings Before Tax

4,006

2,843

886

365

-87

Income tax

-1,046

image

image

image

image

Minority interests, Income from Affiliates & Other

-54

image

image

image

image

UNDERLYING EARNINGS GROUP SHARE

2,908

image

image

image

image

Contractual Service Margin stock 

230

image

image

image

image

(in Euro million, except percentages)

June 30, 

2023

 

Commercial

lines

 

Personal lines

 

AXA XL

Reinsurance

 

Intercompany eliminations 

 

Short-term Business

 

 

 

 

 

Revenues

25,254

17,117

8,470

1,121

-1,455

Combined Ratio

90.9%

90.9%

93.6%

80.8%

image

Technical Margin

2,288

1,556

544

215

-28

Financial Results & Other

1,193

891

228

81

-7

Underlying Earnings Before Tax

3,480

2,447

772

297

-35

Income tax

-761

image

image

image

image

Minority interests, Income from Affiliates & Other

-2

image

image

image

image

UNDERLYING EARNINGS GROUP SHARE

2,717

image

image

image

image

Contractual Service Margin stock 

212

image

image

image

image

(in Euro million, except percentages)

June 30,

2024

 

France

Europe

AXA XL

o/w AXA

XL

Insurance

Asia,

Africa &

EMELATAM

Transversal & Central

Holdings

Short-term Business

 

 

 

 

 

 

Revenues

27,294

4,393

10,060

9,022

7,867

2,855

963

Combined Ratio

90.2%

87.8%

90.3%

87.7%

89.0%

98.0%

100.1%

Technical Margin

2,682

538

977

1,111

865

57

-1

Financial Results & Other

1,324

251

473

273

159

242

86

Underlying Earnings Before Tax Income Tax

4,006

788

1,450 -352

1,384 -352

1,024 -257

299 -77

85

-15

-1,046

-249

Minority interests, Income from Affiliates & Other

-54

0

-25

0

0

-28

0

UNDERLYING EARNINGS GROUP SHARE

2,908

539

1,073

1,032

767

194

70

(in Euro million, except percentages)

June 30,  2023

France

Europe

AXA XL

o/w AXA

XL

Insurance

Asia,

Africa &

EMELATAM

Transversal & Central

Holdings

Short-term Business

 

 

 

 

 

 

 

Revenues

25,254

4,046

9,244

8,670

7,549

2,417

878

Combined Ratio

90.9%

90.7%

90.1%

89.0%

90.2%

97.9%

100.4%

Technical Margin

2,288

377

911

953

737

52

-4

Financial Results & Other

1,193

258

484

232

151

172

46

Underlying Earnings Before Tax

3,480

635

1,395

1,185

888

224

42

Income Tax

-761

-126

-329

-236

-180

-61

-10

Minority interests, Income from Affiliates & Other

-2

-1

-24

0

0

23

0

UNDERLYING EARNINGS GROUP SHARE                                 2,717            508         1,042            949            708            186                 32

On a reported basis, Property & Casualty Underlying Earnings amounted to €2,908 million, up €190 million (+7%).

On a constant exchange rate basis, Property & Casualty Underlying Earnings increased by €185 million (+7%), fuelled by (i) a strong growth in gross written premiums across business lines, (ii) favorable technical results (€+379 million), (iii) higher financial results (€+142 million) driven by significant increase in investment income (€+449 million) thanks to higher reinvestment yields on fixed income assets, more than compensating the increase in the unwind of the discount of claims reserves (€-307 million) resulting from the increase in interest rates experienced since 2022. This was partly offset by (iv) higher income taxes (€-285 million) due to higher pre– tax Underlying Earnings as well as the impact of the OECD Pillar Two minimum taxation rules implemented in 2024.

AY Combined Ratio improved by -0.7 points to 90.2%, mainly driven by (i) a more favorable undiscounted current year loss ratio excluding Natural Catastrophe charges (-0.8 point) from the continued improvements in attritional claims in Commercial lines following strong pricing actions to mitigate impacts from inflation, combined with improvement in Personal lines due to underwriting measures in response to higher frequency in Motor observed in the second half of 2023, notably in United Kingdom & Ireland and Germany, and (ii) favorable prior years’ reserve developments (-0.9 point to -1.5% of combined ratio). This was partly offset by (iii) higher Natural Catastrophe charges (+0.5 point to 3.6%) in Europe and in France, (iv) the decrease in current year discount (+0.3 point to -3.9%), driven by the lower average interest rates across most geographies, and (v) higher expenses (+0.1 point) due to the increase in commission expenses (+0.2 point) driven by business mix changes, partly offset by the improvement of the non-commission ratio (-0.1 point). 

             

LIFE & HEALTH 

(in Euro million, except percentages)

June 30, 2024

Life

Health

Short-term Business

 

7,979

 

 

Revenues

2,112

5,867

Combined Ratio

97.6%

94.5%

98.6%

Technical Margin

195

116

79

Long-term Business

 

1,395

 

 

CSM Release

1,136

259

Technical Experience

-64

-71

7

Financial Result & Other

 

536

 

 

Financial Result

454

82

Underlying Earnings Before Tax

2,061 -412

1,634

427

Income Tax 

-316

-96

Minority interests, Income from Affiliates & Other

76

74

2

UNDERLYING EARNINGS GROUP SHARE

1,725

1,392

333

Contractual Service Margin stock

33,333

25,939

7,395

(in Euro million, except percentages)

June 30, 2023

Life

Health

Short-term Business

 

 

 

Revenues

7,142

1,970

5,172

Combined Ratio

98.9%

93.8%

100.8%

Technical Margin

80

122

-43

Long-term Business

 

 

 

CSM Release

1,474

1,202

272

Technical Experience

-41

-52

11

Financial Result & Other

 

 

 

Financial Result

431

350

81

Underlying Earnings Before Tax

1,944

1,622

322

Income Tax 

-381

-305

-76

Minority interests, Income from Affiliates & Other

81

81

0

UNDERLYING EARNINGS GROUP SHARE

1,643

1,398

245

Contractual Service Margin stock (a)

34,116

26,639

7,476

(a) Life Contractual Service Margin is restated following the termination in 2024 of the sale agreement of a closed life and pensions portfolio at AXA Germany, classified as held for sale as of June 30, 2023.

(in Euro million, except percentages)

June 30,

2024

 

 

7,979

France

 

Europe

 

AXA XL

 

Asia,

Africa &

EME-

LATAM

 

Transversal & Central

Holdings 

 

 

Short-term Business

 

 

 

 

 

Revenues

4,654

1,778

0

1,457

90

Combined Ratio

97.6%

96.7%

98.8%

0.0%

99.1%

92.2%

Technical Margin

195

 

155

21

0

13

7

Long-term Business

 

 

 

 

 

CSM Release

1,395

407

468

4

516

0

Technical Experience

-64

-40

-11

3

-17

0

Financial Result & Other

 

 

 

 

 

 

Financial Result

536

100

284

10

142

0

Underlying Earnings Before Tax

2,061

622

762

17

654

7

Income Tax 

-412

-106

-180

-3

-123

0

Minority interests, Income from Affiliates & Other

76

1,725

4

-23

0

96

0

UNDERLYING EARNINGS GROUP SHARE

519

559

14

627

7

Asia,

Transversal

                                                                                           June 30,                                                             Africa &

(in Euro million, except percentages)                                                         France         Europe        AXA XL                          & Central

                                                                                                2023                                                                EME-

Holdings 

LATAM

                                                                                                

Short-term Business

Revenues

7,142

4,386

1,441

0

1,185

130

Combined Ratio

98.9%

96.8%

106.1%

0.0%

97.8%

98.9%

Technical Margin

80

140

-87

0

26

1

Long-term Business

 

 

 

 

 

 

CSM Release

1,474

433

487

1

553

0

Technical Experience

-41

-39

5

0

-6

0

Financial Result & Other

 

 

 

 

 

 

Financial Result

431

98

226

7

101

0

Underlying Earnings Before Tax

1,944

631

630

8

673

1

Income Tax 

-381

-100

-148

-2

-131

0

Minority interests, Income from Affiliates & Other

81

7

-32

0

106

0

UNDERLYING EARNINGS GROUP SHARE                                      1,643             538             449                 6             648                   1

On a reported basis, Life & Health Underlying Earnings amounted to €1,725 million, up €82 million (+5%).

On a constant exchange rate basis and excluding the impact of the reinsurance agreements on in-force portfolios in France and AXA Life Europe, as well as the acquisition of Laya in Ireland, Life & Health Underlying Earnings increased by €134 million (+8%) from (i) a higher short-term business technical margin (€+105 million) reflecting 1.2 points decrease in the combined ratio, mostly in Europe (€+97 million) driven by United Kingdom & Ireland from the turnaround plan implemented in response to the increase in Health claims frequency observed in 2023, and in France (€+15 million) mostly driven by Health. (ii) Long-term business technical margin decreased by (€-21 million) mainly from the recognition of a loss component in Italy resulting from the widening of government spreads, while the release of the Contractual Service Margin remained stable (€+1 million) as favorable model and assumption changes in 2024, enabling better profitability recognition, was offset by the adverse impact of the net outflows last year, notably in France which did not impact the first half of 2023. (iii) Financial result increased (€+99 million) notably in Europe and Asia, Africa & EME-LATAM reflecting higher yields and an improved funds distribution. This was partly offset by (iv) higher income taxes (€-51 million) from higher pre-tax Underlying Earnings.

ASSET MANAGEMENT 

On a reported basis, Asset Management Underlying Earnings amounted to €204 million, up €16 million.

On a constant exchange rate basis, Asset Management Underlying Earnings increased by €16 million (+8%) driven by (i) higher revenues (€+8 million), (ii) higher investment income (€+6 million) from higher interest rates and higher income from seed capital, (iii) lower expenses (€+6 million) from cost containment measures compensated by higher staff expenses to support business, partly offset by (iv) lower income from affiliates and associates (€-1 million) and (v) higher taxes (€-2 million) from higher pre-tax Underlying Earnings.

HOLDINGS

image

On a reported basis, Holdings Underlying Earnings amounted to €-592 million, down €-155 million.

On a constant exchange rate basis, Holdings Underlying Earnings decreased by €154 million mainly driven by (i) Transversal & Central Holdings (€-93 million) driven by further investments in technology and growth initiatives, and (ii) Europe (€-59 million) mostly from United Kingdom & Ireland due to the non-repeat of favorable tax one-offs.  

NET INCOME

image

On a reported basis, Net Income amounted to €4,020 million, up €187 million (+5%).

On a constant exchange rate basis, Net Income increased by €225 million (+6%) as:

•       the increase in Underlying Earnings, up €158 million to €4,244 million combined with; 

•       favorable net realized capital gains, up €135 million to €93 million in both fixed income and Investment properties notably in Japan;

•       lower unfavorable change in the fair value of assets and derivatives, improving by €47 million to €43 million as (i) the increase in the fair value of mutual funds (€+73 million) mainly from hedge funds was more than offset by (ii) the unfavorable change in the fair value of derivatives (€-115 million) mainly hedging equity (€-55 million) and forex (€-16 million); combined with

•       lower negative impact of goodwill and other related intangibles, improving by €43 million to €-50 million from the amortization of intangibles at AXA XL, in Switzerland and at AXA Tianping; as well as

•       lower integration and restructuring costs, improving by €4 million to €-78 million, mainly consisting of costs (i) at AXA XL (€-25 million) from IT productivity initiatives, including automation, (ii) United Kingdom & Ireland (€-21 million) notably from the integration of Laya in Ireland, as well as (iii) at AXA Life Europe (€-9 million) from project costs in relation with the implementation of a reinsurance agreement on an in-force portfolio; were partly offset by:

•       higher negative impact of exceptional items, down €162 million to €-146 million, mainly from (i) Reso (€-115 million) driven by the net profit of the period including the impairment of both Reso-owned frozen assets and AXA's receivable on dividends declared by Reso combined with (ii) the disposal of India Life (€-42 million).

SHAREHOLDERS’ EQUITY GROUP SHARE                                                                                      

image

As of June 30, 2024, Shareholders' equity Group share totaled €47.3 billion. The movements in Shareholders' equity Group share since December 31, 2023, are presented in the table below:

(in Euro million) 

Shareholders’ equity Group share

At December 31, 2023

49,579 73

Paid-in Capital

Treasury Shares

-1,628

Other Comprehensive Income Arising from Defined Benefit Plans

220

Fair Value Recorded in Shareholders' Equity

-1,148

          Other Comprehensive Income Related to Invested Assets

-5,473

         Other Comprehensive Income Related to (re) Insurance Contracts

4,325

Impact of Currency Fluctuations

315

Realized Gains on Equity through Retained Earnings

5

Undated Subordinated Debt (including interest charges)

212

Dividends

-4,370

Net Income for the Period

4,020

Other

62

47,340

At June 30, 2024

SOLVENCY INFORMATION(1)

image

As of June 30, 2024, the Group’s Eligible Own Funds (“EOF”) amounted to €57.7 billion and the Solvency II ratio to 227%, compared to €57.4 billion and 227% as of December 31, 2023.

image 

(1) Solvency-related information included in this section, including the Solvency II ratio and the Eligible Own Funds (“EOF”), is not subject to the review of the Half Year 2024 Consolidated Financial Statements included in the Half Year 2024 Financial Report, nor the verification of the information otherwise included in such Half Year 2024 Financial Report, performed by the Group’s statutory auditors.


 

Shareholder value EARNINGS PER SHARE (“EPS”) 

image

Underlying Earnings Per Share on a fully diluted basis amounted to €1.87, up 4%.

 

(in Euro, except ordinary shares in million)

June 30, 2024

June 30, 2023

June 30, 2024/  June 30, 2023

Basic

Fully diluted

Fully

Basic diluted

Basic

Fully diluted

Weighted average number of shares 

Net income (Euro per ordinary share)

2,209 

2,215 

            2,241              2,247 

-1%

-1%

1.77 

1.77 

              1.67                1.67 

6%

6%

Underlying earnings (Euro per ordinary share)

1.87 

1.87 

              1.79                1.79 

4%

4%

RETURN ON EQUITY (“ROE”) 

image

(in Euro billion)

June 30, 2024

15.7%

June 30, 2023

June 30, 2024 /  June 30, 2023

Net Income ROE

15.5%

0.3 pts 

Net Income TUV

3.9 

3.7 

 

Average Adjusted Shareholders' Equity TWV

49.7 

16.6%

48.4 

 

Underlying ROE

16.6%

0.0 pts 

Underlying Earnings TUV

4.1 

4.0 

 

Average Adjusted Shareholders' Equity TWV

49.7 

48.4 

 

                                               

(a)               Including adjustments to reflect net financial charges related to undated and deeply subordinated debt (recorded through shareholders' equity).

(b)               Excluding reserves related to the change in fair value of invested assets and derivatives, reserves related to insurance contracts  as well as undated and deeply subordinated debt (recorded through shareholders' equity).

             

Outlook

AXA has made a good start to its new strategic plan “Unlock the Future”, delivering strong operational performance in the first half of 2024. This reflects the strength of its business model, which is balanced between Commercial and Retail lines and diversified across geographies. Management is confident in achieving underlying earnings per share growth in 2024 in line with the 6-8% CAGR plan target(1) range over 2023-2026E period. 

In Property & Casualty, the pricing environment remains favorable. Management believes that this environment is conducive to sustaining the Group’s strong underwriting margins in Commercial lines and to improving the margins in Personal lines, notably in Europe through pricing and underwriting actions. 

In Life & Health, Management expects the recovery in the technical margin in UK Health to continue in the second half of 2024, reflecting the impact from ongoing price increases and underwriting measures.

Results in Holdings reflect investments in technology and growth initiatives that are expected to remain at a similar level in the second half of the year.

Assuming a definitive agreement is reached and the sale of AXA Investment Managers to BNP Paribas is completed, the Group would exit the asset management business(2). The Group will continue to recognize the earnings of AXA Investment Managers until the expected completion of the proposed transaction. Upon completion, the Group plans to launch a share buy-back to offset the underlying earnings per share dilution that would result from the proposed transaction.

In this context, Management is confident in the Group’s ability to deliver on the main financial targets of AXA’s

“Unlock the Future” plan: (i) underlying earnings per share growth of 6-8% CAGR target range between 2023 and 2026E, (ii) underlying return on equity between 14% and 16% between 2024 and 2026E, and (iii) cumulative organic cash upstream in excess of €21 billion for 2024-2026E. Management also affirms the capital management policy(3) of the Group’s “Unlock the Future” strategic plan, targeting a total payout ratio of 75%(4), comprising a 60% dividend payout ratio and an additional 15% from annual share buy-backs(5). The policy also includes a dividend per share floor, whereby the proposed dividend per share in a given year is expected to be at least equal to the dividend per share paid in the prior year.

AXA’s strategy is focused on delivering profitable organic growth and scaling technical excellence across its businesses, while driving operational excellence across its entire organization. AXA’s Management believes that the Group is well placed to create lasting shareholder value and offer an attractive return.

image 

(1) Assuming current operating and market conditions persist and based on a Nat Cat load of ca. 4.5 points, defined as normalized natural catastrophes losses expected in a year expressed in percentage of gross earned premiums for the same year. Natural Catastrophe charges include natural catastrophe losses regardless of event size. 

(2) The completion of the transaction is subject to customary closing conditions, including the information and consultation of employees’ representative bodies, followed by the signing of the Share Purchase Agreement and the receipt of regulatory approvals, and is expected to be finalized by the second quarter of 2025. Please refer to the Press Release “AXA enters into an exclusive negotiation to sell AXA Investment Managers to BNP Paribas” published on August 1, 2024, and available on AXA’s website (www.axa.com).

(3) Subject to annual Board and Shareholders’ Annual General Meeting approvals and absent (1) for share buy-backs, any significant earnings event (i.e., significant deviation in the Group’s underlying earnings) and (2) for dividends, the occurrence of a significant capital event (i.e., event that significantly deteriorates Group solvency). Board discretion includes taking into account AXA’s earnings, financial condition, applicable capital and solvency requirements, prevailing operating and financial market conditions and the general economic environment.

(4) Payout ratio is calculated based on underlying earnings per share.

(5) Annual share buy-backs exclude share buy-backs related to the neutralization of earnings dilution from disposal and in-force management transactions, as well as well as to neutralize the dilution resulting from employee share offerings and stock-based compensation.

Glossary

SCOPE 

image

•       France (insurance and banking activities, and holding); •            Europe, consisting of: o      Switzerland (insurance activities), o          Germany (insurance activities and holding), o Belgium & Luxemburg (insurance activities and holding), o         United Kingdom & Ireland (insurance activities and holding), o Spain (insurance activities), o           Italy (insurance activities), and o             AXA Life Europe (insurance activities); 

•       AXA XL (insurance and reinsurance activities and holding);

•       Asia, Africa & EME-LATAM consisting of

o   Asia, consisting of:

§   Japan (insurance activities and holding),

§   Hong Kong (insurance activities),

§   Thailand (insurance activities),

§   Indonesia (insurance activities),

§   China (insurance activities),

§   The Philippines (insurance activities),

§   South Korea (insurance activities),

§   India (Life activities disposed on March 11, 2024 and holding), and

§   Asia Holdings; o    EME-LATAM, consisting of:

§   Brazil (insurance activities and holding),

§   Colombia (insurance activities),

§   Mexico (insurance activities),

§   Russia (Reso) (insurance activities), and

§   Türkiye (insurance activities and holding), o    Africa:

§   Morocco (insurance activities and holding),

§   Nigeria (insurance activities and holding),  o AXA Mediterranean Holdings;

•       AXA Investment Managers (includes, Select (previously referred to as Architas), Capza, and Asian joint ventures accounted for under the equity method);

•       Transversal & Central Holdings, consisting of:

o   AXA Assistance, o AXA Liabilities Managers,

o   AXA SA (including Group’s internal reinsurance activity consequently to the merger with AXA Global Re on June 30, 2022), and

o   Other Central Holdings.

ALTERNATIVE PERFORMANCE MEASURES

image

Information on the Group’s Alternative Performance Measures is incorporated herein by reference to the section “Alternative Performance Measures” on pages 559 to 560 of the 2023 Universal Registration Document in its Appendix IV “Glossary”.

OTHER DEFINITIONS  

image

Information on the Group’s Other Definitions is incorporated herein by reference to the section “Other Definitions” on pages 560 to 562 of the 2023 Universal Registration Document in its Appendix IV “Glossary”. 


 

 

 

 

II.  Consolidated Interim Financial Statements 

 

/

 

June 30, 2024

  

 

 

GIE_AXA_Internal

 

Contents

II.1 CONSOLIDATED STATEMENT OF FINANCIAL POSITION............................................................................................... 33

II.2 CONSOLIDATED STATEMENT OF PROFIT OR LOSS........................................................................................................ 35

II.3 CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME...................................................................................... 36

II.4 CONSOLIDATED STATEMENT OF CHANGES IN EQUITY................................................................................................ 37

II.5 CONSOLIDATED STATEMENT OF CASH FLOWS............................................................................................................. 38

II.6 NOTES TO THE CONSOLIDATED INTERIM FINANCIAL STATEMENTS........................................................................... 40

NOTE 1 ACCOUNTING PRINCIPLES.................................................................................................................................. 40

NOTE 2 SCOPE OF CONSOLIDATION................................................................................................................................ 43

NOTE 3 CONSOLIDATED STATEMENT OF PROFIT OR LOSS BY SEGMENT..................................................................... 47

NOTE 4 TRANSACTIONS IN CONSOLIDATED ENTITIES................................................................................................... 50

NOTE 5 INVESTMENTS...................................................................................................................................................... 51

NOTE 6 SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS..................................................................... 59

NOTE 7 INSURANCE AND REINSURANCE CONTRACTS.................................................................................................. 64

NOTE 8 FINANCING DEBT................................................................................................................................................. 80

NOTE 9 FINANCIAL RESULT, EXCLUDING FINANCING DEBT EXPENSES......................................................................... 81

NOTE 10 NET INCOME PER ORDINARY SHARE............................................................................................................... 83

NOTE 11 SUBSEQUENT EVENTS....................................................................................................................................... 84

In this document, unless provided otherwise, “restated” refers to the comparative period that was restated following the termination in 2024 of the sale agreement of a closed life and pensions portfolio at AXA Germany, classified as held for sale in 2023. Please refer to Note 4.

II CONSOLIDATED INTERIM FINANCIAL STATEMENTS

II.1 CONSOLIDATED STATEMENT OF FINANCIAL POSITION 

Notes

(in Euro million) 

June 30,  2024

December 31, 2023, restated

 

 

Goodwill

Other intangible assets 

18,171 

17,855  4,630 

4,653 

Intangible assets 

22,823 

22,485 

Investments in real estate properties 

Financial investments 

Assets backing contracts where the financial risk is borne by policyholders 

28,904 

29,542 

406,932 

82,753 

403,418 

86,635 

5

Investments from insurance activities 

518,957 

519,227 

5

Investments from banking and other activities 

19,775 

20,812 

 

Investments accounted for using the equity method 

1,753 

1,938 

 

 

Assets arising from insurance contracts and investment contracts with discretionary participation features 

Assets arising from reinsurance contracts held 

11 

25,211 

25,541 

7

Assets arising from insurance contracts, investment contracts, and reinsurance contracts held 

25,547 

25,222 

 

 

   of which present value of future cash flows    of which risk adjustment for non-financial risk

22,827 

24,059  488 

492 

 

   of which contractual service margin

2,228 

675 

  

 

Derivative assets  Tangible assets 

Deferred tax assets 

11,156 

2,095 

3,337 

8,919 

2,372 

3,603 

Other assets 

14,894 

16,588 

Current tax receivables 

Other receivables 

848 

721 

11,882 

11,910 

 

Receivables 

12,758 

12,603 

 

Assets held for sale

346 

127 

 

Cash and cash equivalents 

22,077 

25,384 

TOTAL ASSETS 

638,931 

644,385 

image


Notes

(in Euro million) 

June 30,  2024

December 31, 2023, restated

 

Shareholders’ equity – Group share 

47,340 

49,579 

 

of which Net income - Group share 

4,020 

7,189 

 

Non-controlling interests 

2,742 

2,819 

6

TOTAL SHAREHOLDERS' EQUITY 

50,082 

52,398 

 

Subordinated debt 

11,099 

11,020 

 

Financing debt instruments issued 

3,227 

2,411 

8

Financing debt 

14,326 

13,431 

7

Liabilities arising from insurance contracts and investment contracts with discretionary participation features 

461,855 

469,031 

 

Liabilities arising from other investment contracts 

12,303 

12,110 

7

Liabilities arising from reinsurance contracts held 

 

Liabilities arising from insurance contracts, investment contracts, and reinsurance contracts held 

474,166 

481,149 

 

   of which present value of future cash flows

435,290 

443,162 

 

   of which risk adjustment for non-financial risk

3,085 

3,125 

 

   of which contractual service margin

35,792 

34,862 

 

Liabilities arising from banking activities 

10,313 

10,603 

 

Provisions for risks and charges 

4,964 

5,439 

 

Derivative liabilities 

13,275 

13,948 

 

Deferred tax liabilities 

2,116 

1,728 

 

Other liabilities 

15,391 

15,676 

 

Non-controlling interests of controlled investment funds and puttable instruments held by non-controlling interests

8,934 

7,593 

 

Other debt instruments issued, notes and bank overdrafts 

12,484 

11,064 

 

Current tax payables  

1,575 

1,279 

 

Collateral debts relating to investments under a lending agreement or equivalent 

33,968 

32,079 

 

Other payables 

12,728 

13,672 

 

Payables 

69,689 

65,688 

 

Liabilities held for sale

TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES 

638,931 

644,385 

image

II.2 CONSOLIDATED STATEMENT OF PROFIT OR LOSS                                          

Notes

(in Euro million, except EPS in Euro) 

June 30,  2024

June 30,  2023

7

Insurance revenue 

42,288  117 

39,194  118 

Fees and charges relating to investment contracts with no discretionary participation features 

Revenues from other activities 

1,125 

1,403 

 

Revenues from all activities

43,529 

(35,555)

(2,279)

40,715 

7

7

Insurance service expenses

(33,627) (1,209)

Net expenses from reinsurance contracts held 

Expenses from other activities 

(1,613)

(1,505)

 

Expenses from all activities 

(39,447) 4,082 

(36,341)

 

Result from all activities 

4,374 

9

Net investment income

6,426  423 

5,549 

(1,300)

Net realized gains and losses relating to investments at cost and at fair value through Other Comprehensive

Income (OCI)

Net realized gains and losses and change in fair value of investments at fair value through profit or loss

4,322 

4,532 

 

Change in impairment on investments

(211)

(161)

9

Investment return 

10,960 

(9,924) 726 

8,620 

7

7

Net finance income or expenses from insurance contracts issued 

(7,603) 155 

Net finance income or expenses from reinsurance contracts held 

 

Net finance income or expenses from insurance and reinsurance contracts 

(9,198) 1,762 

(7,448)

 

Financial result excluding financing debt expenses

1,172 

Other income and expenses

(107)

(0) (107)

(509) (1)

Change in impairment on goodwill and other intangible assets 

Other operating income and expenses 

(510)

Operating profit before tax 

5,737 

60  (292)

5,037 

Income (net of impairment) from investments accounted for using the equity method 

200 

(306)

Financing debts expenses 

 

Profit before tax 

5,505 

(1,390)

4,931 

Income tax 

(994)

 

Net income 

4,115 

4,020 

3,937 

 

Split between: 

3,833 

Net income - Group share 

Net income - Non-controlling interests

94 

104 

10

10

Earnings per share 

1.77 

1.77 

1.67 

1.67 

Fully diluted earnings per share 

 

image

II.3 CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

(in Euro million) 

June 30,  2024

June 30,  2023

Net income

4,115 

3,937 

Changes in fair value of financial instruments TUV

Net finance income and expenses from insurance contracts issued

(6,018)

4,747 

(4,165)

5,032 

Net finance income and expenses from reinsurance contracts held

Foreign currency translation differences 

(336)

395 

(781)

302 

Items that may be reclassified subsequently to Profit or Loss 

(1,020)

195 

Realized capital gains or losses on equity instruments, without recycling in Profit or Loss TXV

31 

Change in fair value of equity instruments, without recycling in Profit or Loss TWV TXV

Actuarial gains and losses from defined benefit plans

133 

349 

568 

221 

Change in fair value of financial liabilities attributable to changes in credit risk 

(1)

(1)

Items that may not be reclassified subsequently to Profit or Loss 

356 

(663)

947 

Other comprehensive income, net of tax 

1,142 

TOTAL COMPREHENSIVE INCOME FOR THE PERIOD 

3,452 

5,079 

        Split between:                                                                                                                                                                                                                                                                       

Comprehensive Income - Group share

3,412 

4,927 

Comprehensive Income - Non-controlling interests

40 

152 

                         

(a) Including changes in the fair value of cash flows hedge reserve and cost of hedging reserve.                          

(b) Including changes in the fair value hedge reserve of equity instruments.

(c)  Including reactivity from insurance contracts, without recycling in Profit or Loss.                                      

    image                                                              Half Year 2024 Financial Report                                                                                 36

GIE_AXA_Internal


 

                                                                                                                                        CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

 II.4 CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 

(in Euro million, except for number of shares and nominal value)

Number of shares 

(in thousands)

Nominal

value 

(in Euro)

Paid-in capital

Other reserves recognized through OCI

Undated subordinated debts

Translation reserves

Employee benefits

Retained earnings

Shareholders' equity group share

Noncontrolling interests

Total

shareholders' equity

Shareholders' equity opening January 1, 2024

2,270,189 

2.29 

22,130 

(6,327)

5,439 

(2,442)

(2,364)

33,143 

49,579 

2,819 

52,398 

Paid-in capital 

1,314 

2.29 

29 

-   

-   

-   

-   

-   

29 

-   

29 

Share based compensation 

-   

-   

44 

-   

-   

-   

-   

-   

44 

-   

44 

Treasury shares

-   

-   

(1,628)

-   

-   

-   

-   

-   

(1,628)

-   

(1,628)

Undated subordinated debt

-   

-   

-   

-   

334 

-   

-   

(123)

212 

-   

212 

Others (including effect of changes in scope of consolidation)

-   

-   

-   

(0)

-   

(0)

63 

63 

(117)

(54)

Dividends paid

-   

-   

-   

-   

-   

-   

-   

(4,370)

(4,370)

-   

(4,370)

Impact of transactions with shareholders

1,314 

2.29 

(1,555)

(0)

334 

(0)

(4,430)

(5,650)

(117)

(5,767)

Net income

-   

-   

-   

-   

-   

-   

-   

4,020 

4,020 

94 

4,115 

Other comprehensive income (OCI)

-   

-   

-   

(1,148)

21 

294 

220 

(609)

(54)

(663)

Total comprehensive income for the period

-   

-   

-   

(1,148)

21 

294 

220 

4,024 

3,412 

40 

3,452 

Shareholders' equity closing June 30, 2024

2,271,503 

2.29 

20,575 

(7,475)

5,794 

(2,148)

(2,144)

32,737 

47,340 

2,742 

50,082 

II

image 

(in Euro million, except for number of shares and nominal value)

Number of shares 

(in thousands)

Nominal

value 

(in Euro)

Paid-in capital

Other reserves recognized through OCI

Undated subordinated debts

Translation reserves

Employee benefits

Retained  earnings

Shareholders' equity group share

Noncontrolling interests

Total

shareholders' equity

Shareholders' equity opening January 1, 2023

2,351,771 

2.29 

23,317 

(8,758)

5,704 

(1,643)

(2,652)

30,102 

46,072 

3,018 

49,090 

Paid-in capital 

Share based compensation 

Treasury shares

Undated subordinated debt

Others (including effect of changes in scope of consolidation)

Dividends paid

(57,732)

-    

-    

-    

-    

-    

2.29  -    

-    

-    

-    

-    

(1,384)

22  150 

-    

-    

-    

-    

-    

-    

-    (0) -    

-    

-    

-    (0) -    

-    

-    

-    

-    

-   

(0) -    

-    

-    

-    

-    

-   

-    

-    

-    

-    

(92)

5  (3,787)

(1,384)

22 

150 

(92)

5  (3,787)

-    

-    

-    

-    

(264)

-    

(1,384)

22 

150 

(92)

(259) (3,787)

Impact of transactions with shareholders

(57,732)

2.29 

(1,212)

(0)

(0)

(0)

-   

(3,874)

(5,086)

(264)

(5,350)

Net income

Other comprehensive income (OCI)

-    

-    

-    

-    

-    -    

-    

1,273 

-    5 

-    

(772)

-    

565 

3,833  23 

3,833  1,094 

104  48 

3,937  1,142 

Total comprehensive income for the period                                                                    -                    -                      -                           1,273                              5                    (772)                     565                3,856                                                                                                                                                    4,927               152                5,079 

imageShareholders' equity closing June 30, 2023                                                       2,294,039                2.29          22,106                       (7,485)                     5,709                (2,415)               (2,087)             30,084                                                                                                                                             45,912                 2,906         48,819 

 

                                                                                                                                Half Year 2024 Financial Report                                                                                                                                                                                                                                                                                                                                                                                                 37


 

II.5 CONSOLIDATED STATEMENT OF CASH FLOWS

(in Euro million) 

June 30,  2024

June 30,  2023, restated

Profit before tax 

5,505 

4,931 

          Net amortization expense TUV

(355)

(299)

          Change in goodwill impairment and other intangible assets impairment TWV

          Net increase / (write back) in impairment on investments and tangible assets 

236 

186 

          Change in fair value of assets and liabilities at fair value through profit or loss 

(5,333)

(4,877)

          Net change in liabilities arising from insurance and investment contracts TXV

(2,709)

2,476 

          Net increase / (write back) in other provisions TYV

(67)

(74)

          Income arising from investments in associates - Equity method 

(60)

(200)

Adjustment of non cash balances included in the operating income before tax 

(8,288)

(2,787)

          Net realized gains and losses 

617 

1,595 

          Financing debt expenses 

292 

306 

Adjustment of balances included in operating income before tax for reclassification to investing or financing activities 

908 

1,900 

          Dividends recorded during the period 

(1,758)

(1,515)

          Investment income & expense recorded in profit or loss during the period

(4,726)

(3,995)

Adjustment of transactions from accrued to cash basis 

(6,485)

(5,510)

          Net cash impact of deposit accounting

(197)

(470)

          Dividends and interim dividends collected 

2,504 

1,618 

          Interests collected

8,435 

7,100 

          Interests paid (excluding interests on financing and undated subordinated debts, margin calls and other)

(3,100)

(1,917)

          Net operating cash from banking activities 

(23)

(473)

          Net change in operating receivables and payables 

10,099 

(239)

          Net cash provided by other assets and liabilities 

(2,205)

406 

          Tax expenses paid 

(803)

(496)

          Other operating cash impact and non cash adjustment 

86 

149 

Net cash impact of transactions with cash impact not included in the operating income before tax 

14,795 

5,677 

NET CASH PROVIDED / (USED) BY OPERATING ACTIVITIES

6,435 

4,212 

          Purchase of subsidiaries and affiliated companies, net of cash acquired 

(232)

(0)

          Disposal of subsidiaries and affiliated companies, net of cash ceded 

71 

15 

          Net cash related to changes in scope of consolidation 

(161)

14 

          Sales and/or repayment of debt instruments TZV

25,788 

22,332 

          Sales of equities instruments TZV T[V

9,288 

8,663 

          Sales of investment properties held directly or not 

950 

(69)

          Sales and/or repayment of loans and other assets TZV T\V

11,305 

7,530 

          Net cash related to sales and repayments of investments PQR PSR PTR

47,331 

38,456 

          Purchases of debt instruments TZV

(28,257)

(18,711)

          Purchases of equity instruments TZV T[V

(11,102)

(8,802)

          Purchases of investment properties held direct or not 

(923)

(1,481)

          Purchases and/or issues of loans and other assets TZV T\V

(14,056)

(8,896)

Net cash related to purchases and issuance of investments PQR PSR PTR

(54,338)

(37,890)

          Sales of tangible and intangible assets 

167 

          Purchases of tangible and intangible assets 

(193)

(142)

         image                                                             Half Year 2024 Financial Report                                                                           38

 

Net cash related to sales and purchases of tangible and intangible assets 

(192)

25 

          Increase in collateral payable/Decrease in collateral receivable 

65,815 

61,613 

          Decrease in collateral payable/Increase in collateral receivable 

(62,913)

(62,085)

          Net cash impact of assets lending / borrowing collateral receivables and payables 

2,902 

(473)

          NET CASH PROVIDED/(USED) BY INVESTING ACTIVITIES

(4,459)

133 

          Issuance of equity instruments 

1,527 

159 

          Repayments of equity instruments 

(2,972)

(1,176)

          Transactions on treasury shares 

(11)

          Dividends payout 

(4,447)

(3,938)

          Interests on perpetual debts paid 

(134)

(92)

          Acquisition/sale of interests in subsidiaries without change in control 

-   

-   

          Net cash related to transactions with shareholders 

(6,025)

(5,058)

          Cash provided by financial debts issuance 

768 

1,765 

          Cash used for financial debts repayments 

(0)

(1,008)

          Interests on financing debt paid  

(319)

(382)

NET CASH RELATED TO GROUP FINANCING

449 

376 

NET CASH PROVIDED/(USED) BY FINANCING ACTIVITIES

(5,576)

(4,683)

NET CASH PROVIDED BY DISCONTINUED OPERATIONS

-   

-   

CASH AND CASH EQUIVALENT AS OF JANUARY 1 PUR

24,539 

26,632 

          Net cash provided by operating activities 

6,435 

4,211 

          Net cash provided by investing activities 

(4,459)

133 

          Net cash provided by financing activities 

(5,576)

(4,683)

          Net cash provided by discontinued operations  

-   

-   

          Impact of change in consolidation method and of reclassifications as held for sale

-   

(33)

          Net impact of foreign exchange fluctuations and reclassification on cash and cash equivalents 

517 

91 

CASH AND CASH EQUIVALENT AS OF JUNE 30 PUR

21,456 

26,351 

(a) Includes premiums/discounts capitalization and relating amortization, amortization of investment and owner occupied properties (held directly).

(b) Includes impairment and amortization of intangible assets booked in the context of business combinations.

(c) Includes impact of reinsurance and change in liabilities arising from contracts where the financial risk is borne by policyholders.

(d) Mainly includes change in provisions for risks & charges, for bad debts/doubtful receivables and change in impairment of assets held for sale.

(e) Includes related derivatives.

(f) Includes equity instruments held directly or by consolidated investment funds as well as non consolidated investment funds.

(g) Includes sales/purchases of assets backing insurance & investment contracts where the financial risk is borne by policyholders. (h) Net of bank overdrafts.

(in Euro million) 

June 30,  2024

June 30,  2023, restated

Cash and cash equivalents

22,077 

27,058 

Bank overdrafts TUV

(621)

(707)

Cash and cash equivalents PVR

21,456 

26,351 

(a) Included in "Other debt instruments issued and bank overdrafts" of the consolidated statement of financial position. 

(b) The "Cash and cash equivalents" item excludes cash backing contracts where the financial risk is borne by policyholders (Unit-Linked contracts).

II.6 NOTES TO THE CONSOLIDATED INTERIM FINANCIAL STATEMENTS

NOTE 1 ACCOUNTING PRINCIPLES

1.1 GENERAL INFORMATION

image

AXA SA, a French Société Anonyme (the “Company” and, together with its consolidated subsidiaries, “AXA” or the “Group”), is the holding (parent) company and the internal reinsurer of an international financial services group focused on insurance protection. The list of main entities included in the scope of consolidation is provided in Note 2 hereafter.

AXA is listed on Euronext Paris Compartiment A.

The Consolidated Interim Financial Statements for the period from January 1 to June 30, 2024, including associated Notes, were set by the Board of Directors on August 1, 2024.

1.2 GENERAL ACCOUNTING PRINCIPLES

image

The Consolidated Interim Financial Statements are condensed financial statements prepared in accordance with

IAS 34 - Interim Financial Reporting, on the basis of IFRS and interpretations of the IFRS Interpretations Committee that are endorsed by the European Union before the end of the reporting period with a compulsory date of January 1, 2024.

When applying IFRS 17 - Insurance Contracts, the Group uses the option provided by the European Union which allows not to apply the annual cohort requirement under IFRS 17 for determining the groups of insurance contracts meeting some criteria (refer to paragraph 1.14.3 of Note 1 Accounting principles of the Notes to the 2023 Consolidated Financial Statements included in the 2023 Universal Registration Document).

The 2024 half year Consolidated Interim Financial Statements should be read in conjunction with the Consolidated Financial Statements included in the 2023 Universal Registration Document.

For existing and unchanged IFRS standards and interpretations, the accounting policies applied in the preparation of the Consolidated Interim Financial Statements are consistent with those applied in the preparation of the Consolidated Financial Statements for the year ended December 31, 2023. The nature and effects of amendments to the IFRS standards first applied in the present Consolidated Interim Financial Statements are summarized in paragraph 1.2.1 below.

1.2.1 IFRS requirements adopted on January 1, 2024

The application of the amendments below as of January 1, 2024 had no material impact on the Group’s Consolidated Interim Financial Statements:

•       Amendments to IAS 1 - Presentation of Financial Statements: Classification of Liabilities as Current or Non-current (including the deferral of its effective date) and  Non-current Liabilities with Covenants;

•       Amendments to IFRS 16 - Leases: Lease Liability in a Sale and Leaseback; and

•       Amendments to IAS 7 - Statement of Cash Flows and IFRS 7 - Financial Instruments: Disclosures: Supplier Finance Arrangements.

1.2.2 Standards and amendments published but not yet effective
Amendments to the Classification and Measurement Requirements for Financial Instruments in IFRS 9 - Financial Instruments and IFRS 7 - Financial Instruments: Disclosures

These amendments, issued on May 30, 2024, will be effective on January 1, 2026, with earlier application permitted. They have not yet been endorsed by the European Union.

They result from the post-implementation review of the classification and measurement requirements in IFRS 9 - Financial Instruments and related requirements in IFRS 7 - Financial Instruments: Disclosures. These amendments improve the requirements in IFRS 9 and IFRS 7 related to settling financial liabilities using an electronic payment system as well as to assessing contractual cash flow characteristics of financial assets with contingent features, including those with environmental, social and governance (ESG)-linked features.

The amendments also modify disclosure requirements relating to investments in equity instruments designated at fair value through other comprehensive income and add disclosure requirements for financial instruments with contingent features that do not relate directly to basic lending risks and costs.

The assessment of their impact on the Group’s Consolidated Financial Statements is in progress.

IFRS 18 - Presentation and Disclosure in Financial Statements

IFRS 18 - Presentation and Disclosure in Financial Statements, published on April 9, 2024, will be effective on January 1, 2027, with earlier application permitted. The standard has not yet been endorsed by the European Union.

It is aimed at improving the quality and cross-industry comparability of financial reporting, notably by introducing defined subtotals in the statement of profit or loss, adding new principles for aggregation and disaggregation of information and requiring disclosures about management-defined performance measures. It will replace IAS 1 - Presentation of Financial Statements.

The assessment of its impact on the Group’s Consolidated Financial Statements is in progress.

Other IFRS requirements not yet effective

The amendments to IAS 21 - The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability, published on August 15, 2023 and effective for annual periods beginning on or after January 1, 2025, are not expected to have a material impact on the Group’s Consolidated Financial Statements.

1.2.3 Preparation of financial statements

The preparation of financial statements in accordance with IFRS requires the use of estimates and assumptions. In preparing the Consolidated Interim Financial Statements, significant judgments made by management in applying the Group’s accounting policies and the key sources of estimation uncertainty were the same as those applied to the Consolidated Financial Statements as at the year ended December 31, 2023.

Disclosures relating to the International tax reform (Pillar Two) 

The international tax reform released by Organization for Economic Cooperation and Development (OECD), known as Pillar Two, aims to ensure that an effective taxation of 15 % is reached in each jurisdiction where multinational groups operate. This tax reform is effective in France starting from the 2024 fiscal year. As a result, the Group has to determine the effective tax rate based on Pillar Two rules in each jurisdiction where it operates, and, if this rate is lower than the minimum 15 % rate, an additional tax will have to be paid.

Furthermore, amendments to IAS 12 - Income Taxes issued by the IASB on May 23, 2023 and endorsed by the European Union on November 8, 2023, introduce a mandatory temporary exception in IAS 12, prohibiting both the recognition and disclosure of deferred tax assets and deferred tax liabilities that arise from the implementation of the OECD Pillar Two model rules. The Group applies these amendments starting from 2023.

The Group has initiated a specific project in 2023 to implement Pillar Two model rules. Based on the analysis in progress, main jurisdictions where the Group has an exposure are Bermuda, Ireland and Hong Kong.

In Bermuda, a local corporate income tax of 15 % has been enacted on December 27, 2023. This tax will be effective for fiscal years beginning on or after January 1, 2025. In this context, the Group expects to pay a top-up tax in France on its 2024 expected profits in Bermuda but will be subject to local tax in this jurisdiction starting from fiscal year 2025, which is expected to increase the effective tax rate of the Group in Bermuda and correspondingly reduce any top-up tax requirement in France.

In Ireland, Pillar Two rules have been enacted as of December 18, 2023 and came into effect from January 1, 2024. A local minimum top-up tax has been adopted as part of the overall implementation of the reform.

In Hong Kong, no Pillar Two rules have been enacted yet but a minimum top-up tax at the rate of 15 % is expected to take effect for fiscal years beginning on or after January 1, 2025.

As at June 30, 2024 the current tax expense included €43 million for these new taxes (payable at AXA SA level or at local level in case of local minimum tax being enacted such as in Ireland). This is an estimate, subject to further refinement, as it is based, from one hand, on the calculation method of the effective tax rate Pillar Two which still needs to be clarified on certain aspects and, from the other hand, on projections of results by jurisdictions for corporate entities and most recent financial statements available for investment entities.


NOTE 2 SCOPE OF CONSOLIDATION   

2.1 CONSOLIDATED COMPANIES

image

image

2.1.1 Main fully consolidated companies

June 30, 2024

Voting rights percentage  

Group share of interests 

December 31, 2023

Change in scope 

Voting rights percentage 

Group share of interests 

AXA SA and Other Holdings 

 

 

 

 

 

AXA SA 

CFP Management 

Parent company

100.00

100.00

Parent company

100.00

100.00

AXA Group Operations SAS 

100.00

100.00

100.00

100.00

Société Beaujon 

100.00

100.00

100.00

100.00

AXA China  

100.00

100.00

100.00

100.00

AXA Asia 

100.00

100.00

100.00

100.00

France 

 

 

 

AXA France IARD 

AXA France Vie 

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

AXA Protection Juridique 

99.99

99.99

98.52

98.51

Avanssur 

100.00

99.81

100.00

99.81

AXA France Participations 

100.00

100.00

100.00

100.00

AXA Banque 

100.00

100.00

100.00

100.00

AXA Banque Financement 

65.00

100.00

65.00

100.00

65.00

65.00

Europe 

 

 

 

Germany 

AXA Versicherung AG 

 

100.00

100.00

AXA Lebensversicherung AG 

100.00

100.00

100.00

100.00

Deutsche Ärzteversicherung 

100.00

100.00

100.00

100.00

AXA Krankenversicherung AG 

100.00

100.00

100.00

100.00

Kölnische Verwaltungs AG für Versicherungswerte 

100.00

100.00

100.00

100.00

AXA Konzern AG 

100.00

100.00

100.00

100.00

Roland Rechtsschutz-Versicherungs-AG 

60.00

60.00

60.00

60.00

United Kingdom & Ireland 

Guardian Royal Exchange Plc  

 

100.00

100.00

100.00

100.00

AXA UK Plc 

100.00

100.00

100.00

100.00

AXA Insurance UK Plc 

100.00

100.00

100.00

100.00

AXA PPP Healthcare Limited  

100.00

100.00

100.00

100.00

AXA Insurance Limited 

100.00

100.00

100.00

100.00

AXA Life Europe DAC

Laya Healthcare Limited

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

June 30, 2024

Voting rights percentage  

Group share of interests 

December 31, 2023

Change in scope 

Voting rights percentage 

Group share of interests 

Spain 

AXA Seguros Generales, S.A. 

 

99.93

99.93

99.93

99.93

AXA Aurora Vida, S.A. de Seguros 

99.86

99.86

99.86

99.86

GACM España, S.A.U.

100.00

99.93

100.00

99.93

Switzerland 

AXA Leben AG 

 

100.00

100.00

100.00

100.00

AXA-ARAG Rechtsschutz AG 

66.67

66.67

66.67

66.67

AXA Versicherungen AG 

100.00

100.00

100.00

100.00

Italy 

AXA Assicurazioni e Investimenti 

 

100.00

100.00

100.00

100.00

AXA MPS Vita 

50.00

50.00

50.00

50.00

+ 1 voting right

+ 1 voting right

AXA MPS Danni 

50.00

50.00

50.00

50.00

+ 1 voting right

+ 1 voting right

AXA MPS Financial 

100.00

50.00

100.00

50.00

Belgium and Luxembourg

AXA Belgium SA 

 

100.00

100.00

100.00

100.00

AXA Holdings Belgium 

100.00

100.00

100.00

100.00

Yuzzu SA 

100.00

100.00

100.00

100.00

AXA Assurances Luxembourg 

100.00

100.00

100.00

100.00

AXA Assurances Vie Luxembourg 

100.00

100.00

100.00

100.00

AXA Luxembourg SA 

100.00

100.00

100.00

100.00

AXA XL 

 

 

 

AXA XL (sub group) TUV

100.00

100.00

100.00

100.00

Asia, Africa & EME-LATAM

 

100.00

100.00

100.00

100.00

 

 

National Mutual International Pty Ltd. 

AXA Mediterranean Holding SA 

100.00

100.00

100.00

100.00

Japan 

AXA Holdings Japan 

98.70

98.70

98.70

98.70

AXA Life Insurance  

100.00

98.70

100.00

98.70

AXA General Insurance Co. Ltd. 

100.00

98.70

100.00

98.70

AXA Direct Life Insurance Co. Ltd. 

Merged with

AXA Life Insurance

0.00

0.00

100.00

98.70

Hong Kong 

AXA China Region Limited 

 

100.00

100.00

100.00

100.00

AXA General Insurance Hong Kong Ltd. 

100.00

100.00

100.00

100.00

China 

AXA Tianping 

100.00

100.00

100.00

100.00

(a) AXA XL mainly operates in the United States, the United Kingdom, France, Germany, Australia, Switzerland, Netherlands, Italy, Spain, Bermuda and Canada.

                                                                                                                       

June 30, 2024

Voting rights percentage  

Group share of interests 

December 31, 2023

Change in scope 

Voting rights percentage 

Group share of interests 

Indonesia 

MLC Indonesia 

 

100.00

100.00

100.00

100.00

Thailand 

AXA Insurance Public Company Limited 

 

99.47

86.35

99.47

86.35

South Korea 

AXA General Insurance Co. Ltd. 

 

99.73

99.73

99.73

99.73

Colombia 

AXA Colpatria Seguros 

 

51.00

51.00

51.00

51.00

AXA Colpatria Seguros de vida 

51.00

51.00

51.00

51.00

Morocco 

AXA Assurance Maroc  

 

100.00

100.00

100.00

100.00

AXA Al Amane Assurance 

100.00

100.00

100.00

100.00

AXA Holding Maroc S.A. 

100.00

100.00

100.00

100.00

Turkey 

AXA Hayat ve Emeklilik A.S. 

 

100.00

100.00

100.00

100.00

AXA Sigorta AS 

93.03

93.03

93.03

93.03

AXA Turkey Holding W.L.L 

100.00

100.00

100.00

100.00

Mexico 

AXA Seguros S.A. de C.V. 

 

100.00

100.00

100.00

100.00

AXA Salud S.A. de C.V. 

80.00

80.00

80.00

80.00

Singapore 

AXA Financial Services Singapore pte Ltd. 

 

100.00

100.00

100.00

100.00

India 

AXA India Holding  

100.00

100.00

100.00

100.00

Nigeria 

AXA Mansard Insurance Plc (Nigeria) 

76.48

76.48

76.48

76.48

Brazil

AXA Seguros S.A.

100.00

100.00

100.00

100.00

Other 

 

 

 

AXA Investment Managers (sub group) 

AXA Assistance SA (sub group) 

97.53

100.00

97.53

100.00

97.50

100.00

97.50

100.00

Colisée Ré  

100.00

100.00

100.00

100.00

Architas, Ltd.

100.00

100.00

100.00

100.00

NON-CONTROLLING INTERESTS ON CONTROLLED INVESTMENTS FUNDS AND REAL ESTATE COMPANIES

As of June 30, 2024, non-controlling interests in consolidated investment funds amounted to €8,934 million, (€7,593 million as of December 31, 2023). In most investment funds (particularly open-ended investment funds), non-controlling interests are presented as liabilities under “Non-controlling interests of consolidated investment funds”. Non-controlling interests related to consolidated investment funds and real estate companies that are classified in shareholder’s equity amounted to €1,510 million as of June 30, 2024 (€1,543 million as of December 31, 2023).

2.1.2 Main investments in entities accounted for using the equity method

Companies accounted for using the equity method listed below exclude investment funds and real estate entities:

 

June 30, 2024

Voting rights percentage  

Group share of interests 

December 31, 2023

Change in scope 

Voting rights percentage 

Group share of interests 

France 

 

 

 

 

 

Neuflize Vie 

39.98

39.98

39.98

39.98

Asia, Africa & EME-LATAM

 

 

 

Philippines AXA Life Insurance Corporation 

Krungthai AXA Life Insurance Company Ltd. (Thailand) 

45.00

50.00

45.00

50.00

45.00

50.00

45.00

50.00

ICBC-AXA Life Insurance Co., Ltd. (China) 

27.50

27.50

27.50

27.50

PT AXA Mandiri Financial Services (Indonesia) 

49.00

49.00

49.00

49.00

Reso Garantia (Russia) 

38.61

38.61

38.61

38.61

Bharti AXA Life (India) 

Disposal

0.00

65.74

50.00

0.00

64.12

48.76

49.00

49.00

Other

 

 

 

Capza (Asset Management - France)

Kyobo AXA Investment Managers Company Limited (South Korea) 

65.74

50.00

64.10

48.75

AXA SPDB Investment Managers Company Ltd. (China) 

39.00

38.04

39.00

38.02

 


        

CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

NOTE 3 CONSOLIDATED STATEMENT OF PROFIT OR LOSS BY SEGMENT

AXA’s Chief Executive Officer (CEO), acting as chief operating decision maker, is a member of the Board of Directors. He is assisted by a Management Committee in the operational management of the Group and by a group of senior executives, the Partners Group, in developing and implementing any strategic initiatives. The financial information related to AXA’s business segments and holding companies reported to the Board of Directors twice a year is consistent with the presentation provided in the Consolidated Financial Statements.

The results of operating activities and non-operating activities are presented on the basis of six segments: France, Europe, AXA XL, Asia, Africa & EME-LATAM, AXA Investment Managers, and Transversal & Other.

As of June 30, 2024, the CEOs supervising the main hubs (respectively CEO of AXA France, CEO of AXA in Europe, CEO of AXA XL, CEO of AXA International Markets, and CEO of AXA Investment Managers) are members of the Management Committee. 

Key transversal entities and Central Holdings are managed alongside these hubs.

France: the French market consists of Life & Health and Property & Casualty activities, AXA Banque France and French holdings.

Europe: the European market consists of Life & Health and Property & Casualty activities in Switzerland, Germany, Belgium, Luxembourg, Spain and Italy, Health and Property & Casualty activities in United Kingdom and Ireland as well as Life activities in AXA Life Europe. The holding companies in these countries are also included.

AXA XL: the AXA XL market mainly consists of Property & Casualty activities in XL Group, operating mainly in the United States, the United Kingdom, France, Germany, Australia, Switzerland, Netherlands, Italy, Spain, Bermuda and Canada. The holding companies are also included. 

II

Asia, Africa & EME-LATAM:

The Asian market consists of Life & Health and Property & Casualty activities in Japan, Hong Kong, the Philippines, Thailand and China, Life & Health activities in Indonesia and India (disposed during the first semester of 2024) as well as Property & Casualty and Health activities in South Korea. The holding company in Japan and the other Asia holdings are also included.

The African market consists of Life & Health and Property & Casualty activities in Morocco and Nigeria. The holding companies in these countries are also included.

The EME – LATAM market consists of Life & Health and Property & Casualty activities in Colombia, Mexico and Türkiye, Property & Casualty activities in Brazil and Russia. The holding company in Brazil, Türkiye and other holding companies are also included.

AXA Investment Managers: the AXA Investment Managers (includes, Select (previously referred to as Architas), Capza, and Asian joint ventures accounted for under the equity method) market includes the asset management activity.

Transversal & Other: it includes transversal entities namely AXA Assistance, AXA Liabilities Managers, AXA SA, and other Central Holdings.

The intersegment eliminations include only operations between entities from different countries and operating activities. They mainly relate to reinsurance treaties, assistance guarantees recharging, asset management fees and interests on loans within the Group.

In this document, “Insurance” covers the two insurance activities: Life & Health and Property & Casualty.

image                                                                                                                                                                                                                47

        

 

CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

3.1 CONSOLIDATED STATEMENT OF PROFIT OR LOSS BY SEGMENT

image

 

France 

Europe

AXA XL

June 30, 2024

Asia,

Africa &

EMELATAM

AXA IM

Transversal & Other

Intersegment Eliminations

Total

(in Euro million)

Insurance revenue 

10,916 

15,887  88 

9,171 

-

6,081  29 

-

-

771 

-

(539)

-

42,288  117 

Fees and charges relating to investment contracts with no discretionary participation features 

Revenues from other activities 

38 

143 

36 

23 

937 

282 

(335)

1,125 

Revenues from all activities

10,954 

(9,420) (336)

16,119 

(13,944) (345)

9,207 

(6,332)

(1,694)

6,133 

(5,410) (166)

937 

-

-

1,054 

(825) 77 

(874)

376 

185 

43,529 

(35,555)

(2,279)

Insurance service expenses

Net expenses from reinsurance contracts held 

Expenses from other activities 

(88)

(157)

(21)

(32)

(669)

(1,135)

489 

(1,613)

Expenses from all activities 

(9,845) 1,110 

(14,446) 1,673 

(8,047) 1,160 

(5,609) 524 

(669) 268 

(1,882) (829)

1,050  176 

(39,447) 4,082 

Result from all activities 

Investment return 

3,993 

(4,201)

502 

(3,699)

294 

(110)

-

(110)

3,384 

(2,728)

(71)

(2,799)

585 

(165)

-

(165)

706 

(579)

260 

(319)

386 

(153)

-

(153)

3,033 

(2,346)

(25)

(2,370)

663 

(49)

-

(49)

22 

-

-

-

22 

(33)

-

(33)

140 

(70)

52  (17)

122 

481 

(0) 481 

(318)

(0)

(311)

(78)

-

(78)

10,960 

(9,924)

726 

(9,198)

1,762 

(107)

(0) (107)

Net finance income or expenses from insurance contracts issued 

Net finance income or expenses from reinsurance contracts held

Net finance income or expenses from insurance and reinsurance contracts 

Financial result excluding financing debt expenses

Other income and expenses

Change in impairment on goodwill and other intangible assets 

Other operating income and expenses 

Operating profit before tax 

1,294 

(9)

(8)

2,093 

(0)

(9)

1,393 

-

(25)

1,138 

55 

(11)

257 

14 

(2)

(226)

-

(453)

(213)

-

216 

5,737 

60  (292)

Income (net of impairment) from investments accounted for using the equity method 

Financing debts expenses 

Profit before tax 

1,277  (316)

2,084  (507)

1,368  (349)

1,182  (264)

269  (69)

(678) 117 

(3)

5,505 

(1,390)

Income tax 

Net income 

 

961  

961 

1,577  

1,528 

1,020  

1,020 

918 

 

879 

200 

 

194 

(562) 

(562)

-

 

-

4,115  

4,020 

Split between: 

Net income - Group share 

Net income - Non-controlling interests 

(0)

49 

39 

-

94 

image                                                48 CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

                                                                                                                                                                                  June 30, 2023

Asia,

Africa &

(in Euro million)

France 

Europe

AXA XL

EME-

LATAM

AXA IM

Transversal & Other

Intersegment Eliminations

Total

Insurance revenue 

10,170 

14,766 

8,801 

5,290 

-

723 

(556)

39,194 

Fees and charges relating to investment contracts with no discretionary participation features 

88 

-

30 

-

-

-

118 

Revenues from other activities 

68 

73 

44 

16 

906 

680 

(386)

1,403 

Revenues from all activities

10,238 

14,927 

8,845 

5,336 

906 

1,404 

(942)

40,715 

           Insurance service expenses                                                (8,935)          (12,966)           (6,838)            (4,659)                        -                  (718)                        490           (33,627)

Expenses from all activities 

(9,095)

(7,839)

(4,723)

(651)

(1,752)

1,034 

Result from all activities 

1,144 

1,611 

1,006 

613 

256 

(349)

93 

4,374 

Investment return 

2,481 

3,026 

427 

2,779 

14 

151 

(258)

8,620 

Net finance income or expenses from insurance contracts issued 

(2,607)

(2,567)

(203)

(2,217)

-

(4)

(4)

(7,603)

Net finance income or expenses from reinsurance contracts held

85 

(7)

79 

(4)

-

155 

Net finance income or expenses from insurance and reinsurance contracts 

(2,523)

(2,574)

(124)

(2,221)

-

(2)

(4)

(7,448)

Financial result excluding financing debt expenses

(41)

452 

303 

558 

14 

149 

(261)

1,172 

Other income and expenses

(147)

(114)

(223)

(44)

(36)

72 

(16)

(509)

Change in impairment on goodwill and other intangible assets 

-

-

(1)

-

-

-

-

(1)

Other operating income and expenses 

(147)

(114)

(224)

(44)

(36)

72 

(16)

(510)

Operating profit before tax 

955 

1,949 

1,085 

1,127 

233 

(128)

(184)

5,037 

Income (net of impairment) from investments accounted for using the equity method 

(0)

-

179 

13 

-

-

200 

Financing debts expenses 

(5)

(8)

(26)

(13)

(0)

(438)

185 

(306)

Profit before tax 

958 

1,941 

1,059 

1,293 

246 

(567)

4,931 

Income tax 

(177)

(426)

(221)

(214)

(65)

111 

(1)

(994)

Net income 

781 

1,515 

839 

1,079 

181 

(456)

-

3,937 

Split between: 

Net income - Group share 

780 

1,460 

838 

1,034 

176 

(456)

-

3,833 

Net income - Non-controlling interests 

54 

44 

-

104 

imageNet expenses from reinsurance contracts held                  (63)                (256)              (977)              (42)                -                       25                   104                 (1,209) Expenses from other activities               (96) image               (24)                (22)                (651)              (1,059)          440  image

image                                                49                                                                                   CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

NOTE 4 TRANSACTIONS IN CONSOLIDATED ENTITIES      

4.1 DISPOSAL OF A CLOSED LIFE AND PENSION PORTFOLIO IN GERMANY

image

On May 2, 2024, AXA and Athora Deutschland GmbH (“Athora Germany”), a licensed insurer in Germany, mutually agreed to terminate the sale agreement related to a closed life and pensions portfolio in AXA Germany, which was initially communicated on July 14, 2022. AXA will retain this portfolio, which is well capitalized and duration matched.

As a consequence, the related assets and liabilities were no longer classified as held for sale as of June 30, 2024, and the consolidated statement of financial position as of December 31, 2023, has been restated accordingly in this report.

The major classes of assets and liabilities (net of intercompany balances with other AXA entities), which have been restated from held for sale, are presented in the table below:

          ASSETS                                                                                                                                                                        

(In Euro million)

December 31,  2023 published

December 31, 2023, restated

Effect of restatement

Assets held for sale

13,060 

-   

(13,060) 

Investments from insurance activities

-   

12,455 

12,455 

Assets arising from insurance contracts, investment contracts, and reinsurance contracts held

-   

Other assets

-   

186 

186 

Cash and cash equivalents

-   

412 

412 

TOTAL ASSETS

13,060 

13,060 

(0) 

           LIABILITIES                                                                                                                                                                 

(in Euro million) 

December 31,  2023 published

December 31, 2023, restated

Effect of restatement

Liabilities held for sale

12,795 

 -   

(12,795) 

Liabilities arising from insurance contracts, investment contracts, and reinsurance contracts held

-   

12,155 

12,155 

Other liabilities 

-   

640 

640 

TOTAL LIABILITIES

12,795 

12,795 

(0) 

image                                                                                                                                                                                                                 50


NOTE 5 INVESTMENTS

It should be noted that the amounts disclosed in the present Note as impacting the Group’s consolidated comprehensive income do not consider the induced effects relating to insurance liabilities, notably those arising from contracts with direct participating features (see Note 7) and, therefore, do not represent net ultimate gains or losses recognized in the consolidated statement of comprehensive income.

5.1 BREAKDOWN OF INVESTMENTS

image

The tables below present the fair value and the carrying value of the Group’s investments, broken down by (i) class of investments, (ii) classification category according to IFRS 9 - Financial Instruments (namely, investments measured at amortized cost, at fair value through other comprehensive income (“FV OCI”) or at fair value through profit or loss (“FV P&L”) and (iii) activity to which those investments are allocated:

 

(in Euro million, except percentages)

June 30, 2024

Insurance 

Other activities 

Total

Fair value 

Carrying value 

% of total investments

Fair value 

Carrying value 

% of total investments

Fair value 

Carrying value 

% of total investments

Investments in real estate properties at amortized cost (A)

37,002 

    28,904               5.6%

     3,071           3,043             15.4%

40,073 

31,947 

5.9%

Debt instruments at amortized cost 

Debt instruments at FV OCI

Debt instruments at FV P&L - FV Option 

Debt instruments at FV P&L - Mandatory

14,435 

    15,667              3.0%

           9                    9              0.0%

14,444 

15,676 

2.9%

281,929 

281,929                 54.3%

     4,885            4,885             24.7%

image

53.2%

1,105 

      1,105              0.2%

            -                     -             0.0%

1,105 

1,105 

0.2%

14,724 

    14,724              2.8%

         45                  45              0.2%

14,770 

14,770 

2.7%

Debt instruments (B)

312,194 

313,425                 60.4%

     4,940           4,940             25.0%

image

59.1%

Equity instruments at FV OCI without recycling to P&L Equity instruments at FV P&L

12,459 

    12,459              2.4%

     1,356            1,356              6.9%

13,815 

13,815 

2.6%

17,079 

    17,079              3.3%

        486               486               2.5%

17,565 

17,565 

3.3%

Equity instruments (C)

29,538 

    29,538               5.7%

     1,842           1,842               9.3%

31,380 

31,380 

5.8%

Non consolidated investment funds at FV P&L (D)

18,689 

    18,689               3.6%

       129                129               0.7%

18,818 

18,818 

3.5%

Other assets at FV P&L, held by consolidated investment funds (E)

22,204 

    22,204               4.3%

       761                761               3.9%

22,966 

22,966 

4.3%

Financial investments excluding loans (F=B+C+D+E) 

382,625 

383,857                 74.0%

     7,672           7,672             38.8%

image

72.7%

Loans at amortized cost 

Loans at FV P&L - FV Option 

Loans at FV P&L - Mandatory

15,934 

    16,078              3.1%

     9,052            9,061             45.8%

24,986 

25,138 

4.7%

3,462 

      3,462              0.7%

            -                     -             0.0%

3,462 

3,462 

0.6%

21 

          21              0.0%

            -                     -             0.0%

21 

21 

0.0%

Loans (G)

19,417 

    19,561               3.8%

     9,052           9,061             45.8%

28,469 

28,621 

5.3%

Total financial investments (H=F+G)

402,043 

403,418                 77.7%

16,724               16,732             84.6%

418,766 

420,150 

78.0%

Assets backing contracts where the financial risk is borne by policyholders (I)

86,673 

    86,635             16.7%

            -                     -             0.0%

86,673 

86,635 

16.1%

INVESTMENTS (J=A+H+I)

525,718 

518,957                100.0%

19,794               19,775            100.0%

545,512 

538,732 

100.0%

Investments (excluding those backing contracts where the financial risk is borne by policyholders) (K=J-I)

439,045 

432,322                 83.3%

19,794               19,775            100.0%

458,839 

452,097 

83.9%

                                                                                                                                                                                                               December 31, 2023, restated

                                                                                                                                                       Insurance                                                  Other activities                                                       Total

(in Euro million, except percentages)

Fair value 

Carrying value 

% of total investments

Fair value 

Carrying value 

% of total investments

Fair value 

Carrying value 

% of total investments

Investments in real estate properties at amortized cost (A)

38,360

29,542

5.7%

3,030

3,001

14.4%

41,391

32,543

6.0%

Debt instruments at amortized cost 

14,729

16,062

3.1%

9

9

0.0%

14,738

16,072

3.0%

Debt instruments at FV OCI

288,233

288,233

55.5%

5,014

5,014

24.1%

293,246

293,246

54.3%

Debt instruments at FV P&L - FV Option 

1,356

1,356

0.3%

0

0

0.0%

1,356

1,356

0.3%

Debt instruments at FV P&L - Mandatory

13,489

13,489

2.6%

46

46

0.2%

13,535

13,535

2.5%

Debt instruments (B)

Equity instruments at FV OCI without recycling to P&L

12,137

12,137

2.3%

1,617

1,617

7.8%

13,753

2.5%

Equity instruments at FV P&L

15,626

15,626

3.0%

486

486

2.3%

16,112

16,112

3.0%

Equity instruments (C)

27,763

27,763

5.3%

2,103

2,103

10.1%

29,865

29,865

5.5%

Non consolidated investment funds at FV P&L (D)

18,595

18,595

3.6%

142

142

0.7%

18,737

18,737

3.5%

Other assets at FV P&L, held by consolidated investment funds (E)

21,332

21,332

4.1%

756

756

3.6%

22,088

22,088

4.1%

image61.5%                                                                                                                                                                                                              5,069            5,069             24.4%              322,875                                            60.0%

Financial investments excluding loans (F=B+C+D+E) 

image                                                                                                                     74.5%                  8,070            8,070             38.8%              393,566                                  73.1%

Loans at amortized cost 

16,110

16,387

3.2%

9,741

9,741

46.8%

25,851

4.8%

Loans at FV P&L - FV Option 

3,698

3,698

0.7%

0

0

0.0%

3,698

3,698

0.7%

Loans at FV P&L - Mandatory

17

17

0.0%

0

0

0.0%

17

17

0.0%

Loans (G)

19,825

20,103

3.9%

9,741

9,741

46.8%

29,566

29,844

5.5%

Total financial investments (H=F+G)

405,321

406,932

78.4%

17,811

17,811

85.6%

423,132

424,743

78.7%

Assets backing contracts where the financial risk is borne by policyholders (I)

82,449

82,753

15.9%

0

0

0.0%

82,449

82,753

15.3%

INVESTMENTS (J=A+H+I)

526,131

519,227

100.0%

20,841

20,812

100.0%

546,972

540,039

100.0%

Investments (excluding those backing contracts where the financial risk is borne by policyholders) (K=J-I)

443,682

436,474

84.1%

20,841

20,812

100.0%

464,523

457,286

84.7%

Unless otherwise specified, the information disclosed in the following paragraphs of Note 5 does not include the amounts related to the Group’s investments backing contracts where the financial risk is borne by policyholders.

5.2INVESTMENT IN REAL ESTATE PROPERTIES

image

Investments in real estate properties include buildings owned directly and through consolidated real estate entities. 

Real estate properties held by AXA are measured at amortized cost. The table below presents the carrying value (disclosing separately cumulated amortization and impairment) and the fair value of those investments.

(in Euro million) 

June 30, 2024

Gross value

December 31, 2023

Carrying Amortization                       Impairment value

Fair value

Gross value

Amortization

Impairment

Carrying value

Fair value

Total investments in real estate properties

35,113 

          (1,504)                 (1,662)

31,947 

40,073 

35,594 

        (1,575)                (1,476)          32,543 

41,391 

 

The following table provides a reconciliation from the opening balances to the closing balances for the cumulated amounts of impairment and amortization on investment in real estate properties:

(in Euro million) 

Impairment

Amortization

June 30, 2024

December 31, 2023

June 30, 2024

December 31, 2023

Opening balance

1,476 

1,320 

1,575 

1,449 

Increase

Write back following sale or reimbursement

Write back following recovery in value

Other impacts (a)

196  (2)

299 

48 

118 

(37)

(43)

(31)

(11) 4 

(130)

-   

-   

24 

(76)

38 

Closing balance

1,662 

1,476 

1,504 

1,575 

(a) Includes impacts of changes in scope of consolidation and movements in exchange rates.  

 

 

5.3UNREALIZED GAINS AND LOSSES ON FINANCIAL INVESTMENTS

image

The tables below disclose unrealized capital gains and losses not reflected in the consolidated statement of profit or loss (“P&L”), that are related to financial investments measured at amortized cost or at fair value through OCI (“FV OCI”). These unrealized capital gains and losses are broken down by class of financial instruments and IFRS 9 classification category and presented separately for investments allocated to the insurance activity and to other activities: Insurance

 

June 30, 2024

Amortized cost

Decemb

Fair value

er 31, 2023, restated

Carrying         Unr value

ealized gains 

 Unrealized losses 

 (in Euro million)  

 Amortized cost 

 Fair value 

 Carrying       Unr value 

ealized gains 

 Unrealized losses 

 Debt instruments at FV OCI 

300,330 

281,929 

281,929 

8,720 

27,121 

298,528 

288,233  14,729 

288,233  16,062 

13,255  47 

23,551  1,380 

 Debt instruments at amortized cost 

15,667 

14,435 

15,667 

39 

1,271 

16,062 

 Equity instruments at FV OCI without recycling to P&L 

10,004 

12,459 

12,459 

3,261 

806 

10,267 

12,137 

12,137 

2,656 

787 

 Loans at amortized cost  

16,078 

15,934 

16,078 

109 

252 

16,387 

16,110 

16,387 

40 

317 

TOTAL

342,078 

324,758 

326,133 

12,129 

29,450 

341,245 

331,208 

332,819 

15,998 

26,035 

Other Activities

 

June 30, 2024

Amortized cost

         Fair     C

value

December 31, 2023 arrying            Unre value

alized gains 

 Unrealized losses 

 (in Euro million)  

 Amortized cost 

 Fair value 

 Carrying       Unre value 

alized gains 

 Unrealized losses 

 Debt instruments at FV OCI 

5,329 

4,885 

4,885 

450 

5,359 

5,014 

9  1,617 

5,014 

9  1,617 

43 

0  180 

389 

0  70 

 Debt instruments at amortized cost 

-   

1,507 

 Equity instruments at FV OCI without recycling to P&L 

1,255 

1,356 

1,356 

253 

152 

 Loans at amortized cost  

9,061 

9,052 

9,061 

9,741 

9,741 

9,741 

 TOTAL 

15,654 

15,302 

15,311 

260 

611 

16,617 

16,381 

16,382 

223 

459 

Total

 

June 30, 2024

Amortized cost

Decemb

Fair value

er 31, 2023, restated

Carrying         Unr value

ealized gains 

 Unrealized losses 

 (in Euro million)  

 Amortized cost 

 Fair value 

 Carrying       Unr value 

ealized gains 

 Unrealized losses 

 Debt instruments at FV OCI 

305,659  15,676 

286,815  14,444 

286,815  15,676 

8,727  39 

27,571  1,271 

303,888 

293,246  14,738 

293,246  16,072 

13,298  47 

23,940  1,380 

 Debt instruments at amortized cost 

16,072 

 Equity instruments at FV OCI without recycling to P&L 

11,259 

13,815 

13,815 

3,514 

958 

11,774 

13,753 

13,753 

2,836 

856 

 Loans at amortized cost  

25,138 

24,986 

25,138 

109 

261 

26,129 

25,851 

26,129 

40 

317 

 TOTAL 

357,732 

340,060 

341,444 

12,389 

30,061 

357,862 

347,589 

349,200 

16,221 

26,494 

5.4FINANCIAL INVESTMENTS SUBJECT TO IMPAIRMENT

image

The tables below set out the Group’s portfolio of financial investments subject to impairment, namely debt instruments and loans measured at amortized cost or at fair value through OCI (“FV OCI”), broken down by class of financial investments, IFRS 9 classification category and IFRS 9 impairment stage (see Paragraph 1.9.2.2 of Note 1 Accounting principles of the Notes to the 2023 Consolidated Financial Statements included in the 2023 Universal Registration Document), namely: 

•       stage 1: financial investments for which credit risk has not increased significantly since initial recognition, and the loss allowance is measured at an amount equal to 12 months expected credit losses; 

•       stage 2: not credit-impaired financial investments for which credit risk has increased significantly since initial recognition, and the loss allowance is measured at an amount equal to lifetime expected credit losses; 

•       stage 3: financial investments which were not purchased or originated credit impaired but became credit impaired since their initial recognition, and for which the loss allowance is measured at an amount equal to lifetime expected credit losses.

 

(in Euro million) 

June 30, 2024

Cost before impairment and revaluation to fair value

Impairment 

Cost after impairment but before

revaluation to fair value

Revaluation to fair value 

Carrying value 

Stage 1                                                                                                                                                                                                                                                                                       

 Debt instruments at amortized cost  

15,663 

(16)

15,647 

-   

15,647 

 Debt instruments at FV OCI 

305,656 

(48)

305,608 

(19,056)

286,552 

 Debt instruments (A) 

321,320 

(65)

321,255 

(19,056)

302,199 

 Loans at amortized cost (B) 

24,009 

(46)

23,963 

-   

23,963 

 Total Stage 1 (C=A+B) 

345,329 

(111)

345,218 

(19,056)

326,162 

 Stage 2                                                                                                                                                                                                                                                                                      

 Debt instruments at amortized cost  

96 

(68)

29 

-   

29 

 Debt instruments at FV OCI 

33 

(7)

25 

220 

246 

 Debt instruments (D) 

129 

(75)

54 

220 

274 

 Loans at amortized cost (E) 

609 

(23)

586 

-   

586 

 Total Stage 2 (F=D+E) 

738 

(98)

640 

220 

860 

 Stage 3                                                                                                                                                                                                                                                                                      

 Debt instruments at FV OCI 

48 

(22)

26 

(8)

17 

 Debt instruments (G) 

48 

(22)

26 

(8)

17 

 Loans at amortized cost (H) 

826 

(237)

589 

-   

589 

 Total Stage 3 (I=G+H) 

874 

(259)

614 

(8)

606 

Total                                                                                                                                                                                                                                                                                                                               

 Total debt instruments at amortized cost  

15,760 

(84)

15,676 

15,676 

 Total debt instruments at FV OCI 

305,737 

(78)

305,659 

(18,844)

286,815 

 Total debt instruments (J=A+D+G) 

321,497 

(162)

321,335 

(18,844)

302,491 

 Total loans at amortized cost (K=B+E+H) 

25,444 

(306)

25,138 

-   

25,138 

 Total financial investments subject to impairment (L=J+K) 

346,941 

(468)

346,473 

(18,844)

327,629 

 


December 31, 2023, restated

 

Cost before impairment and revaluation to fair

Cost after impairment but

before

                             revaluation to fair             Revaluation to

Carrying

(in Euro million) 

value

Impairment 

value

fair value 

value 

Stage 1                                                                                                                

 Debt instruments at amortized cost  

 

16,060 

 

(17)

 

16,042 

 -   

16,042 

 Debt instruments at FV OCI 

303,875 

(50)

303,824 

(10,624)

293,200 

 Debt instruments (A) 

319,934 

(67)

319,867 

(10,624)

309,242 

 Loans at amortized cost (B) 

25,116 

(58)

25,058 

-   

25,058 

 Total Stage 1 (C=A+B) 

345,050 

(125)

344,925 

(10,624)

334,300 

 Stage 2                                                                                                               

 Debt instruments at amortized cost  

 

97 

 

(68)

 

29 

 -   

29 

 Debt instruments at FV OCI 

30 

(8)

22 

(6)

16 

 Debt instruments (D) 

127 

(75)

52 

(6)

45 

 Loans at amortized cost (E) 

549 

(22)

527 

-   

527 

 Total Stage 2 (F=D+E) 

676 

(97)

579 

(6)

572 

 Stage 3                                                                                                               

 Debt instruments at FV OCI 

 

65 

 

(24)

 

41 

 

(11)

31 

 Debt instruments (G) 

65 

(24)

41 

(11)

31 

 Loans at amortized cost (H) 

732 

(187)

545 

-   

545 

 Total Stage 3 (I=G+H) 

796 

(211)

586 

(11)

575 

Total 

 Total debt instruments at amortized cost  

 

16,157 

 

(85)

 

16,072 

 

-   

 

16,072 

 Total debt instruments at FV OCI 

303,970 

(82)

303,888 

(10,641)

293,246 

 Total debt instruments (J=A+D+G) 

320,126 

(167)

319,960 

(10,641)

309,318 

 Total loans at amortized cost (K=B+E+H) 

26,396 

(267)

26,129 

-   

26,129 

 Total financial investments subject to impairment (L=J+K)                                346,522                                 (434)                         346,088                           (10,641)                       335,447 

 

5.5 FAIR VALUE OF INVESTMENTS

image

The table below presents the breakdown of the fair value of financial investments and investments in real estate properties by fair value hierarchy level as set in IFRS 13 - Fair Value Measurement (see Paragraph 1.6 of Note 1 Accounting principles of the Notes to the 2023 Consolidated Financial Statements included in the 2023 Universal Registration Document). The carrying value of financial investments measured at fair value through profit or loss (“FV P&L”) or OCI (“FV OCI”) is equal to their fair value.

 

 

Financial assets quoted in an active market

June 30, 2024

Financial assets not quoted in an active market or no active market

Total

December 31, 2023, restated

Financial assets quoted in an active market

Financial assets not quoted in an active market or no active market

Total

(in Euro million) 

Level 1 PYR

Level 2 PVR

Level 3 PZR

Level 1 PYR

Level 2 PVR

Level 3 PZR

Debt instruments

216,671 

69,859 

285 

286,815 

221,306 

71,656 

284 

293,246 

Equity instruments

9,196 

1,209 

3,409 

13,815 

9,101 

1,231 

3,422 

13,753 

Financial assets at FV OCI (A)

225,867 

71,068 

3,694 

300,630 

230,406 

72,887 

3,706 

307,000 

Debt instruments

8,127 

5,832 

811 

14,770 

7,559 

5,116 

860 

13,535 

Equity instruments

4,313 

1,658 

11,594 

17,565 

3,892 

1,243 

10,976 

16,112 

Non consolidated investment funds

2,626 

7,987 

8,205 

18,818 

2,064 

8,677 

7,997 

18,737 

Other assets, held by consolidated investment funds 

2,343 

7,757 

12,866 

22,966 

1,863 

6,940 

13,285 

22,088 

Loans

-   

17 

21 

-   

17 

-   

17 

Financial assets at FV P&L  (excluding FV option) (B)

17,409 

23,250 

33,480 

74,139 

15,378 

21,993 

33,118 

70,489 

Debt instruments

1,105 

-   

-   

1,105 

1,356 

-   

-   

1,356 

Loans

-   

3,462 

-   

3,462 

-   

3,698 

-   

3,698 

Financial assets at FV P&L - FV Option (C)

1,105 

3,462 

-   

4,567 

1,356 

3,698 

-   

5,053 

Total financial investments at fair value (D=A+B+C)

244,381 

97,781 

37,174 

379,336 

247,140 

98,579 

36,824 

382,543 

Investments in real estate properties

Debt instruments

39,031 

1,042 

40,073 

40,268  9,482 

1,123 

5,088 

41,391 

14,738 

600 

9,069 

4,775 

14,444 

169 

Loans

10,806 

14,180 

24,986 

11,323 

14,527 

25,851 

Total investments at amortized cost (E)

601 

58,906 

19,997 

79,503 

169 

61,073 

20,738 

81,980 

TOTAL (F=D+E)

244,982 

156,687 

57,171 

458,839 

247,309 

159,652 

57,562 

464,523 

(a) Level 1: fair value determined directly by reference to an active market. 

(b) Level 2: fair value mainly based on observable market data. 

(c)  Level 3: fair value mainly not based on observable market data. 

          

TRANSFERS BETWEEN LEVEL 1 AND LEVEL 2 FOR THE INVESTMENTS MEASURED AT FAIR VALUE

During the first half of 2024, the bid-to-ask spread tightening across the board led to transfers from level 2 to level

1.

During the period ended on June 30, 2024, the net transfer from Level 2 to Level 1 was €+3,767 million. This amount comprised €2,521 million transferred from Level 1 to Level 2, of which €1,276 million for Corporate bonds and €1,107 million for Government bonds, and €6,288 million from Level 2 to Level 1, of which €4,286 million for Corporate bonds and €1,108 million for Government bonds. 

TRANSFER IN AND OUT OF THE LEVEL 3 CATEGORY AND OTHER MOVEMENTS FOR THE INVESTMENTS MEASURED AT FAIR VALUE

From January 1, 2024 to June 30, 2024, the amount of level 3 assets increased by €+0.3 billion to €37.2 billion, representing 9.8% of the total assets at fair value (9.6% as of December 31, 2023 or €36.8 billion, restated).

Main movements relating to level 3 assets to be noted were the following:

•       €+2.0 billion of new investments;

•       €-0.4 billion of change in unrealized gains and losses;

•       €+0.5 billion of net asset transfers, in (€+0.8) and out (€-0.2) of level 3;

•       €-0.2 billion of foreign exchange fluctuation impact;

•       €-0.2 billion of change in scope and other impacts;

•       €-1.4 billion of asset sales, redemptions and settlements mainly equity securities, non-consolidated investment funds, other assets held by controlled investment funds and debt instruments accounted as fair value through profit and loss.

A majority of assets classified in level 3 corresponds to private investments, in particular private equity assets.

NOTE 6 SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS

The consolidated statement of changes in equity is presented as a primary Consolidated Interim Financial Statement.

6.1 IMPACT OF TRANSACTIONS WITH SHAREHOLDERS

image

6.1.1 Change in shareholders’ equity group share for the first half of 2024
SHARE CAPITAL AND CAPITAL IN EXCESS OF NOMINAL VALUE

During the first half of 2024, the following transactions had an impact on AXA’s share capital and capital in excess of nominal value:

•       shared based payments for €44 million.

•       capital increase of €29 million due to the exercise of stock options for 1.3 million shares.

TREASURY SHARES

As of June 30, 2024, the Company and its subsidiaries owned 89.2 million AXA shares, representing 3.9% of the share capital, an increase of 45.2 million shares compared to December 31, 2023, mainly driven by the Share Buy Back programs announced and executed over the first half of the year for 53.9 million shares or €1,800 million.

The 0.7 million treasury shares backing contracts where the financial risk is borne by policyholders held in controlled investment funds were not deducted from shareholders’ equity. Their total estimated historical cost was €18 million, and their market value was €23 million at the end of June 2024.

The carrying value of treasury shares was €3,005 million. No AXA shares were held directly by AXA subsidiaries or by consolidated mutual funds other than those backing contracts where financial risk is borne by policyholders.

UNDATED SUBORDINATED DEBT AND RELATED FINANCIAL EXPENSES

Undated subordinated debt instruments are classified in shareholders’ equity at their historical value and their closing value as regards exchange rates. The corresponding exchange differences are cancelled out through the translation reserve.

During the first half of 2024, the following transactions pertaining to undated deeply subordinated debt had an impact on AXA’s other reserves:

•       €+1,500 million from a new issuance, partly offset by the partial reimbursement of two debts tranches through tender offers for €-1,166 million in total.

•       €-106 million from interest expenses related to undated subordinated debts (net of tax).

•       €+21 million from foreign exchange rate fluctuations.

•       €-17 million from premium on repayment.


As of June 30, 2024 and December 31, 2023, undated subordinated debts recognized in shareholders’ equity were as follows:

 

(in Euro million) 

June 30, 2024

Value of the undated debt in currency of issuance

Value of the undated debt in Euro million

December 31, 2023

Value of the undated debt in currency of issuance

Value of the undated debt in Euro million

October 29, 2004 - 375 M€ 6%

375

375

                     375                                   375

December 22, 2004 - 250 M€ 6%

250

250

                     250                                   250

January 25, 2005 - 250 M€ 6%

250

250

                     250                                   250

July 6, 2006 - 350 M£ 6.6862%

16

19

                     350                                   404

December 14, 2006 - 750 M US$  6,3790%

461

428

                     461                                   415

November 7, 2014 – 984 M€ 3.941%

984

981

                     984                                   981

November 7, 2014 – 724 M£ 5.453%

62

73

                     724                                   833

January 16, 2024 – €1500m RT1 - 6,375%

1,500

1,500

                        0                                        0

May 20, 2014 - 1.000 M€ - 3.875% until October 2025

1,000

997

                   1,000                                   997

Perpetual notes - variables rates in €

625

625

                     625                                   625

Perpetual notes - 3.29% in JPY

27,000

157

                 27,000                                   173

Perpetual notes - (of which 500 M US$ at 7,1%) in US$

150

140

                     150                                   136

TOTAL                                                                                                                                                                                                      5,794                                                                          5,439

image

Undated deeply subordinated debt often contains the following features:

•       include early redemption clauses (calls) at the Group’s option, giving AXA the ability to redeem on certain dates the principal amount, and;

•       often include interest rate step-up clauses with effect from a given date.               

DIVIDENDS PAID

At the Shareholders’ meeting held on April 23, 2024, shareholders approved a dividend distribution of €1.98 per share corresponding to €4,370 million with respect to the 2023 financial year.

6.1.2 Change in shareholders’ equity Group share for the first half of 2023
SHARE CAPITAL AND CAPITAL IN EXCESS OF NOMINAL VALUE

During the first half of 2023, the following transactions had an impact on AXA’s share capital and capital in excess of nominal value:

•       capital decrease of €-1,402 million corresponding to 58.6 million shares mainly to cancel the shares bought in the context of the share buy back programs;

•       capital increase of €18 million due to the exercise of stock options for 0.8 million shares;

•       shared based payments for €22 million.

TREASURY SHARES

As of June 30, 2023, the Company and its subsidiaries owned 70.1 million AXA shares, representing 3.1% of the share capital, a decrease of 17.2 million shares compared to December 31, 2022.  

The 0.6 million treasury shares backing contracts where the financial risk is borne by policyholders held in controlled investment funds were not deducted from shareholders’ equity. Their total estimated historical cost was €15 million, and their market value was €18 million at the end of June 2023.

The carrying value of treasury shares was €2,093 million. No AXA shares were held directly by AXA subsidiaries or by consolidated mutual funds other than those backing contracts where financial risk is borne by policyholders.

UNDATED SUBORDINATED DEBT AND RELATED FINANCIAL EXPENSES

During the first half of 2023, the following transactions pertaining to undated subordinated debt had an impact on AXA’s other reserves:

•       €+5 million from foreign exchange rate fluctuations; 

•       €-92 million from interest expenses related to undated subordinated debts (net of tax).

DIVIDENDS PAID

At the Shareholders’ meeting held on April 27, 2023, shareholders approved a dividend distribution of €1.70 per share corresponding to €3,787 million with respect to the 2022 financial year.

6.2 COMPREHENSIVE INCOME FOR THE PERIOD

image

The Consolidated Statement of Comprehensive Income, presented as a Primary Financial Statement, includes the net income for the period and the other comprehensive income, the latter reflecting the changes relating to other reserves recognized through other comprehensive income (“OCI”) in accordance with IFRS9 and IFRS17, translation reserves and employee benefits. It also reflects the realized capital gains or losses on equity instruments, without recycling in Profit or Loss.

6.2.1 Comprehensive income for the first half of 2024
OTHER RESERVES RECOGNIZED THROUGH OCI IN ACCORDANCE WITH IFRS9 AND IFRS17

The table below gives detailed information on changes in other reserves recognized through OCI during the first semester of 2024:

(in Euro million)

Fair value reserves relating to financial instruments PYR

Fair value reserves relating to cash flow hedge derivatives

Reserves relating to the cost of hedging

Reserves relating to finance income or expenses from insurance and reinsurance contracts

Total

Balance at January 1, 2024

(7,128)

(4,350)

36 

5,115 

(6,327)

Change in OCI with recycling in Profit or Loss

(5,960)

75 

(28)

4,631 

(1,281)

Change in OCI without recycling in Profit or Loss

436 

-   

-   

(306)

130 

Others (including effect of changes in scope of consolidation)

(0)

(0)

Other comprehensive income

(5,521)

75 

(28)

4,325 

(1,148)

Balance at June 30, 2024

(12,649)

(4,275)

9,441 

(7,475)

(a) Including the fair value hedge of equity instruments

REALIZED CAPITAL GAINS OR LOSSES ON EQUITY INSTRUMENTS

Under IFRS 9, realized capital gains or losses on Equity instruments accounted for at fair value through other comprehensive income are accounted directly in retained earnings, without affecting the net income of the period. For the first half of 2024, the Group share realized gain net of tax amounted to €+5 million.

CURRENCY TRANSLATION RESERVE

The total change in currency translation reserve for the first half year of 2024 amounted to €+302 million of which

€+315 million from Group share and €-13 million from non-controlling interests. This was mainly driven by AXA XL (€+625 million), Hong Kong (€+121 million), United Kingdom (€+73m) partly offset by Switzerland (€-381 million) and Japan (€-254 million). Additionally, the translation reserves included the effect over the reporting period of applying IAS 29 standard related to hyperinflation in Türkiye for €-26 million, of which €-24 million Group share.

EMPLOYEE BENEFITS ACTUARIAL GAINS AND LOSSES

The total impact of employee benefits actuarial gains for the first half year of 2024 amounted to €+221 million (of which €+220 million from Group share and €+1 million from non-controlling interests). This was mainly driven by the investment gains of plan assets in Switzerland and an increase in the discount rates used to value liabilities in the Eurozone. The pension plan in Switzerland is overfunded; the asset ceiling test performed as of June 30, 2024, did not entail any limitation of the net defined benefit asset to be recognized.

6.2.2 Comprehensive income for the first half of 2023
OTHER RESERVES RECOGNIZED THROUGH OCI IN ACCORDANCE WITH IFRS 9 AND IFRS 17

The table below gives detailed information on changes in other reserves recognized through OCI during the first semester of 2023:

Reserves relating

Fair value    to finance income reserves                    Fair value      or expenses from relating to                       reserves relating                Reserves       insurance and financial    to cash flow                       relating to the                     reinsurance

(in Euro million)                                                                                            instruments PYR     hedge derivatives       cost of hedging                       contracts                      Total

Balance at January 1, 2023                                                                                       (17,680)                            (5,207)                              48                            14,081                  (8,758)

Change in OCI with recycling in Profit or Loss

4,486 

147 

(46)

(3,653)

933 

Change in OCI without recycling in Profit or Loss

920 

-   

-   

(581)

339 

Others (including effect of changes in scope of consolidation)

(1)

Other comprehensive income

5,405 

147 

(46)

(4,233)

1,273 

Balance at June 30, 2023

(12,275)

(5,060)

9,849 

(7,485)

(a) Including the fair value hedge of equity instruments.

REALIZED CAPITAL GAINS OR LOSSES ON EQUITY INSTRUMENTS

Under IFRS 9, realized capital gains or losses on Equity instruments accounted for at fair value through other comprehensive income are accounted directly in retained earnings, without affecting the net income of the period. For the first half of 2024, the Group share realized gain net of tax amounted to €+23 million.

CURRENCY TRANSLATION RESERVE

The total change in currency translation reserve for the first half year of 2023 amounted to €-781 million of which

€-767 million from Group share and €-14 million from non-controlling interests. This was mainly driven by AXA XL

(€-401 million), Japan (€-357 million) and China (€-131 million), partly offset by AXA SA (€+191 million) and Switzerland (€+122 million). Additionally, the translation reserves included the effect over the reporting period of applying IAS 29 standard related to hyperinflation in Türkiye for €+40 million, of which €+39 million Group share.

 

EMPLOYEE BENEFIT ACTUARIAL GAINS AND LOSSES

The total impact of employee benefit actuarial gains for the first half year of 2023 amounted to €+568 million (of which €+565 million from Group share and €+3 million from non-controlling interests). This was mainly driven by an increase in the net defined benefit asset of the Swiss pension plan. Measured at half year on AXA’s share in the cost of the future employee benefits, the asset ceiling test performed as of June 30, 2023, did not entail any limitation of the net defined benefit asset to be recognized.

6.3 CHANGE IN NON-CONTROLLING INTERESTS 

image

Under IFRS, non-controlling interests in most investment funds in which the Group invests consist of instruments that holders can redeem at will at fair value and qualify as a liability rather than a shareholders’ equity item. 

6.3.1 Change in non-controlling interests for the first half of 2024

The €-77 million decrease in non-controlling interests to €+2,742 million was mainly driven by the comprehensive income and transactions with non-controlling interest holders:

•       The comprehensive income for the period included the following:

o    Net income attributable to non-controlling interests for €+94 million; o     Reserves relating to changes in fair value through shareholders’ equity for €-42 million; o          Foreign exchange movements for €-13 million; o       Employee benefits actuarial gains and losses for €+1 million.

•       Transactions with non-controlling interests’ holders, mainly included:

o    Decrease in the value of non-controlling interests from investments funds mainly due to market performance and divestment in the funds for €-55 million; o Dividend payout to non-controlling interests’ holders for €-83 million.

6.3.2 Change in non-controlling interests for the first half of 2023

The €-112 million decrease in non-controlling interests to €+2,906 million was mainly driven by the comprehensive income and transactions with non-controlling interest holders:

•       The comprehensive income for the period included the following:

o    Net income attributable to non-controlling interests for €+104 million; o   Reserves relating to changes in fair value through shareholders’ equity for €+51 million; o     Realized gains or losses on equity instruments, without recycling in profit or loss for €+8 million; o   Foreign exchange movements for €-14 million; o          Employee benefits actuarial gains and losses for €+3 million.

•       Transactions with non-controlling interests’ holders, mainly included:

o    Decrease in the value of non-controlling interests from investments funds mainly due to market performance and divestment in the funds for €-111 million; o Dividend payout to non-controlling interests’ holders for €-150 million


II

 

                                                                               CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

NOTE 7 INSURANCE AND REINSURANCE CONTRACTS

This note highlights the effects of contracts within the scope of IFRS 17 on the consolidated statement of financial position and the consolidated statement of profit or loss.

IFRS 17 – Insurance Contracts applies to insurance, reinsurance and investment contracts with discretionary participation features issued, and reinsurance contracts held. The acronyms used in this Note correspond to the following terms:

•       DPF: Discretionary Participation Features

•       LRC: Liability for Remaining Coverage

•       LIC: Liability for Incurred Claims

•       ARC: Asset for Remaining Coverage

•       AIC: Asset for Incurred Claims

•       CSM: Contractual Service Margin

•       OCI: Other Comprehensive Income

•       MRA: Modified Retrospective Approach

•       FVA: Fair Value Approach

•       PVFCF: Present Value of Future Cash Flows

•       RA: Risk Adjustment for non-financial risk

•       BBA: Building Block Approach

•       VFA: Variable Fee Approach

•       PAA: Premium Allocation Approach

7.1                RECONCILIATIONS WITH THE CONSOLIDATED INTERIM FINANCIAL STATEMENTS

image

The tables below enable to reconcile the consolidated statement of financial position and the consolidated statement of profit or loss with information disclosed in the following paragraphs.

These reconciliations consist in excluding the amounts of both insurance and reinsurance receivables and payables, as well as the assets for insurance acquisition cash flows, from the consolidated statement of financial position on one hand, the related amounts affecting the consolidated statement of profit or loss on the other hand.

7.1.1 Reconciliation with the consolidated statement of financial position

The reconciliation of amounts presented in the consolidated statement of financial position with the “carrying amount of insurance contracts and investment contracts with DPF”, as disclosed in paragraph 7.2, is as follows:

Receivables arising from direct insurance and inward reinsurance operations 

Payables arising from direct insurance and inward reinsurance operations 

Assets for insurance acquisition cash flows 

31,286 

(9,693) 233 

27,326 

(10,895)

274 

Carrying amount of insurance contracts and investment contracts with DPF, as disclosed hereinafter

483,675 

485,726 

image 

II

 

                                                                               CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024 

The reconciliation of amounts presented in the consolidated statement of financial position with the "carrying amount of reinsurance contracts held”, as disclosed in paragraph 7.3, is as follows:

Payables arising from outward reinsurance operations 

Receivables arising from outward reinsurance operations 

25,882  (4,528)

14,437 

(4,261)

Carrying amount of reinsurance contracts held, as disclosed hereinafter

46,886 

35,380 

image 

 

7.1.2 Reconciliation with the consolidated statement of profit or loss

The reconciliation of amounts presented in the consolidated statement of profit or loss with both the “Insurance service expenses” and the “Net finance income or expenses from insurance contracts issued recognised in profit or loss”, as disclosed in paragraph 7.2, is as follows:

(in Euro million) 

 June 30, 2024 

 June 30,

2023  (33,627)

Insurance service expenses reported in the consolidated statement of profit or loss

(35,555)

 

Increase in impairment relating to receivables arising from direct insurance and inward reinsurance operations 

 

29 

 

22 

Write back of impairment relating to receivables arising from direct insurance and inward reinsurance operations 

(10)

(10)

Increase in impairment of assets for insurance acquisition cash flows 

-   

-   

Write back of impairment of assets for insurance acquisition cash flows 

-   

-   

Insurance service expenses, as disclosed hereinafter

(35,536)

(33,615)

(in Euro million) 

 June 30, 2024 

 June 30,

2023  (7,603)

Net finance income or expenses from insurance contracts issued, reported in the consolidated statement of profit or loss 

(9,924)

 

Interest income on receivables arising from direct insurance and inward reinsurance operations 

 

(25)

Interest expenses on payables arising from direct insurance and inward reinsurance operations 

26 

(21)

Foreign exchange unrealized gains or losses relating to receivables and payables arising from direct insurance and inward reinsurance operations 

33 

88 

Foreign exchange realized gains or losses relating to receivables and payables arising from direct insurance and inward reinsurance operations

20 

(1)

Net finance income or expenses from insurance contracts issued recognized in profit or loss, as disclosed hereinafter

(9,871)

(7,533)

II

 

                                                                               CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024 

The reconciliation of amounts presented in the consolidated statement of profit or loss with both the “Net expenses from reinsurance contracts held” and the “Net finance income or expenses from reinsurance contracts held, recognised in profit or loss”, as disclosed in paragraph 7.3, is as follows:

(in Euro million) 

June 30, 2024

June 30,

2023

(1,209)

 

Net expenses from reinsurance contracts held, reported in the consolidated statement of profit or loss 

 

Increase in impairment relating to receivables arising from outward reinsurance operations 

Write back of impairment relating to  receivables arising from outward reinsurance operations 

(2,279)

 

-   

(0)

(0)

Net expenses from reinsurance contracts held, as disclosed hereinafter

(2,279)

(1,209)

 

 

(in Euro million) 

June 30, 2024

June 30,

2023

155 

 

Net finance income or expenses from reinsurance contracts held, reported in the consolidated statement of profit or loss 

 

Interest income on receivables arising from outward reinsurance operations 

726 

 

(0)

(0)

Interest expenses on payables arising from outward reinsurance operations 

Foreign exchange unrealized gains or losses relating to receivables and payables arising from outward reinsurance operations 

(24)

(0)

Foreign exchange realized gains or losses relating to receivables and payables arising from outward reinsurance operations

-   

Effect of changes in non-performance risk of reinsurers

17 

(6)

Net finance income or expenses from reinsurance contracts held, recognized in profit or loss, as disclosed hereinafter 

723 

153 


               

II
                   7.2    MOVEMENTS IN BALANCES OF INSURANCE CONTRACTS AND INVESTMENT CONTRACTS WITH DPF

image

7.2.1 Changes in the carrying amount of insurance contracts and investment contracts with DPF, split between remaining coverage and incurred claims components

The two following tables provide an analysis of movements in the carrying amount of insurance contracts and investment contracts with DPF, split between the LRC and the LIC.

image                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  67

 

(in Euro million) 

Analysis of changes occurred during the first semester of 2024, split between LRC and LIC

LRC

LIC

 

 

 

 

 

LIC related to PAA contracts

 

 

Excluding loss

component

Loss component

Total  LRC

LIC related to non PAA contracts

Estimates of  the PVFCF

RA

Total 

Total  LIC

Total 

Opening assets 

Opening liabilities 

(14) 

366,321 

-   

(14) 

368,200 

2,673 

              -                             -                            -   

117,539 

(13) 

485,739 

1,879 

      113,179                   1,687 

114,866 

Net balance as of January 1  (A)

366,308 

1,879 

368,187 

2,673 

      113,179                   1,687 

114,866 

117,539 

485,726 

Insurance revenue coming from contracts under the MRA

(4,689) 

-   

(4,689) 

-   

              -                             -   

-   

-   

(4,689) 

Insurance revenue coming from contracts under the FVA

(2,568) 

-   

(2,568) 

-   

              -                             -   

-   

-   

(2,568) 

Insurance revenue coming from other contracts

(35,030) 

-   

(35,030) 

-   

              -                             -   

-   

-   

(35,030) 

Insurance revenue (B)

(42,288) 

-   

(42,288) 

-   

              -                            -   

-   

-   

(42,288) 

Incurred claims and other insurance service expenses 

-   

(36) 

(36) 

5,830 

        24,597                       192 

24,788 

30,618 

30,582 

Amortisation of insurance acquisition cash flows 

6,020 

-   

6,020 

-   

              -                             -   

-   

-   

6,020 

Losses and reversal of losses on onerous contracts 

-   

53 

53 

-   

              -                             -   

-   

-   

53 

Adjustments to liabilities for incurred claims 

-   

-   

-   

(253) 

          (634)                    (231) 

(865) 

(1,118) 

(1,118) 

Insurance service expenses (C)

6,020 

16 

6,036 

5,577 

       23,963                      (39) 

23,924 

29,500 

35,536 

Investment components (D)

(13,980) 

-   

(13,980) 

13,431 

           549                           -   

549 

13,980 

-   

Insurance service result (E=B+C+D)

(50,248) 

16 

(50,232) 

19,008 

       24,511                      (39)                24,472 

43,480 

(6,751) 

Net finance income or expenses recognized in profit or loss 

Net finance income or expenses recognized in OCI

8,587 

(5,426) 

23 

8,611 

(5,426) 

(7) 

         1,257                           2                   1,259 

1,260  (892) 

9,871 

(6,318) 

-   

          (884)                         (0) 

(885) 

Net finance income or expenses from insurance contracts issued (F)

3,161 

23 

3,184 

(6) 

           373                            2 

374 

368 

3,553 

Total changes in the statement of profit or loss and in OCI (G=E+F)

(47,087) 

40 

(47,047) 

57,561 

-   

19,002 

       24,884                      (38)                24,847 

43,849 

-   

(44,902) 

(3,199) 

57,561  (44,902) 

Premiums received 

Claims and other insurance service expenses paid

57,561 

-   

-   

-   

(19,022) 

              -                             -                            -   

-   

      (25,880)                           -   

(25,880) 

Insurance acquisition cash flows paid 

(7,483) 

-   

(7,483) 

-   

              -                             -   

-   

-   

(7,483) 

Total cash flows  (H)

50,078 

-   

50,078 

(19,022) 

     (25,880)                           -   

(25,880) 

(44,902) 

5,176 

Effect of movements in exchange rates (I)

(3,713) 

(148) 

(3,861) 

(23) 

         (113)                         14 

(99) 

(121) 

(3,982) 

Effect of changes in scope of consolidation and other changes (J)

598 

598 

(9) 

         (634)                            0 

(634) 

(643) 

(45) 

Closing assets 

(10) 

-   

(10) 

              -                             -   

-   

(9) 

Closing liabilities 

366,192 

1,771 

367,963 

2,620 

      111,436                   1,664 

113,101 

115,721 

483,684 

Net balance as of June 30 (K=A+G+H+I+J)

366,183 

1,771 

367,954 

2,621 

      111,436                   1,664              113,100 

115,721 

483,675 

 

 

 

 

 

 

(in Euro million) 

Analysis of changes occurred during the year 2023, restated, split between LRC and LIC

LRC

LIC

 

 

Total 

 

Excluding loss

component

 

Loss component

 

Total 

LRC

 

LIC related to non PAA contracts

LIC related to PAA contracts

 

Total  LIC

Estimates

of 

the PVFCF

RA

Total 

Opening assets 

Opening liabilities 

(4) 

358,647 

-   

(4) 

361,087 

2,631 

              -                           -                            -   

113,283 

(4) 

474,371 

2,441 

      108,876                   1,776 

110,652 

Net balance as of January 1  (A)

358,643 

2,441 

361,084 

2,631 

     108,876                    1,776 

110,652 

113,283 

474,367 

Insurance revenue coming from contracts under the MRA

(11,820) 

-   

(11,820) 

-   

              -                           -   

-   

-   

(11,820) 

Insurance revenue coming from contracts under the FVA

(1,844) 

-   

(1,844) 

-   

              -                           -   

-   

-   

(1,844) 

Insurance revenue coming from other contracts

(67,225) 

-   

(67,225) 

-   

              -                           -   

-   

-   

(67,225) 

Insurance revenue (B)

(80,889) 

-   

(80,889) 

-   

              -                           -   

-   

-   

(80,889) 

Incurred claims and other insurance service expenses 

-   

(202) 

(202) 

11,237 

       49,583                       336 

49,920 

61,156 

60,954 

Amortisation of insurance acquisition cash flows 

11,505 

-   

11,505 

-   

              -                           -   

-   

-   

11,505 

Losses and reversal of losses on onerous contracts 

-   

28 

28 

-   

              -                           -   

-   

-   

28 

Adjustments to liabilities for incurred claims 

Insurance service expenses (C)

Investment components (D)

-   

11,505  (28,415) 

-   

-   

11,332  (28,415) 

(108) 

11,129 

27,516 

         (312)                    (403) 

49,271  (67)  899     -   

(715) 

(823) 

60,333 

28,415 

(823) 

(174) 

49,204 

71,665 

-   

-   

899 

Insurance service result (E=B+C+D)

(97,799) 

(174) 

(97,972) 

38,645 

       50,170                     (67)                  50,103 

88,748 

(9,225) 

Net finance income or expenses recognized in profit or loss  Net finance income or expenses recognized in OCI

13,272  8,864 

56 

13,328  8,864 

(1)  18 

         1,080                          2                    1,081 

1,080 

4,190 

14,409 

13,054 

-   

         4,166                           6 

4,173 

Net finance income or expenses from insurance contracts issued (F)

22,136 

56 

22,192 

17 

         5,246                            8 

5,254 

5,271 

27,463 

Total changes in the statement of profit or loss and in OCI (G=E+F)

(75,662) 

(118) 

(75,781) 

99,113 

-   

38,662 

       55,416                     (59)                  55,357 

94,019 

18,238 

Premiums received 

Claims and other insurance service expenses paid

99,113 

-   

-   

-   

(38,572) 

              -                           -                            -   

-   

(89,976) 

99,113 

(89,976) 

-   

     (51,404)                         -   

(51,404) 

Insurance acquisition cash flows paid 

(13,559) 

-   

(13,559) 

-   

              -                           -   

-   

-   

(13,559) 

Total cash flows  (H)

85,554 

-   

85,554 

(38,572) 

     (51,404)                          -   

(51,404) 

(89,976) 

(4,422) 

Effect of movements in exchange rates (I)

(2,828) 

(174) 

(3,001) 

(66) 

             42                      (34) 

(57) 

(3,058) 

Effect of changes in scope of consolidation and other changes (J)

601 

(270) 

332 

19 

           249                            5 

254 

272 

604 

Closing assets 

(14) 

-   

(14) 

              -                           -   

-   

(13) 

Closing liabilities 

366,321 

1,879 

368,200 

2,673 

      113,179                   1,687 

114,866 

117,539 

485,739 

Net balance as of December 31 (K=A+G+H+I+J)

366,308 

1,879 

368,187 

2,673 

     113,179                  1,687               114,866 

117,539 

485,726 

7.2.2 Changes in the carrying amount of insurance contracts and investment contracts with DPF, broken down by measurement component

The two following tables provide an analysis of movements in the carrying amount of insurance contracts and investment contracts with DPF not measured under PAA, broken down by measurement component, namely (i) the estimate of the PVFCF, (ii) the RA, and (iii) the CSM. However, the carrying amount of insurance contracts measured under the PAA is also reported to reconcile with the opening and closing balances of financial statements.

In this respect, the total amount of RA gross of reinsurance (including contracts measured under the PAA) was €3,085 million at end June 2024 and €3,125 million at end December 2023, restated. The percentile was stable at 65th comprised within the 62.5th-67.5th percentile range considered by the Group as the adequate level of prudence on underlying insurance liabilities.

      

(in Euro million) 

Analysis of changes occurred during the first semester of 2024, broken down by measurement component (only for non PAA contrac

ts)

 

Estimates of the PVFCF

 

RA

CSM

 

Carrying amount of non

PAA contracts

 

Carrying amount of PAA contracts

 

Total

Contracts measured at

transition under  the MRA

Contracts measured at

transition under  the FVA

Other contracts

Total 

CSM

Opening assets 

Opening liabilities 

Net balance as of January 1 (A)

CSM recognized in profit or loss for services provided 

Release of RA

                (73)                                  1                                -                                  -                                59                               59 

                (13)                                -   

           348,824                    136,915 

(13) 

485,739 

           312,518                         1,438                         6,820                         2,487                      25,560 

           312,444                         1,439                         6,820                         2,487                      25,620 

-                                  -           (597)              (128)              (796) 

-                                  (40)     -                       -                       -   

34,868 

34,927 

           348,810                    136,915 

            (1,521)                                -   

                (40)                                -   

485,726 

(1,521) 

(40) 

(1,521) 

-   

Experience adjustments 

                  52                                 2                                -                                  -                                  -   

-   

                  54                                -   

54 

Changes that relate to current services (B)

                  52                            (38)                          (597)                         (128)                          (796) 

(1,521) 

            (1,508)                                -   

(1,508) 

Contracts initially recognized in the period  

            (1,204)                               47                            135                                  0                         1,027 

1,162 

                    5                                -   

Changes in estimates that adjust the CSM

            (1,927)                                 3                          (180)                            199                         1,905 

1,924 

                    0                                -   

Changes in estimates that result in losses and reversal of losses on onerous contracts 

                  34                               (2)                                -                                  -                                  -   

-   

                  32                                -   

32 

Changes that relate to future services (C)

            (3,097)                               48                            (46)                            199                         2,932 

3,086 

                  37                                -   

37 

Adjustments to liabilities for incurred claims 

Changes that relate to past services (D)

               (252)                               (1)                                -                                  -                                  -   

               (252)                              (1)                                -                                  -                                  -   

-   

               (253)                                -   

               (253)                                -   

(253) 

(253) 

-   

Insurance service result (E=B+C+D)

            (3,297)                                 9                          (643)                              72                         2,136                        1,565 

            (1,723)                                -   

(1,723) 

Net finance income  or expenses recognized in profit or loss 

Net finance income  or expenses recognized in OCI

              8,513                                 0                               68                              14                               20                             102 

              8,616                                -   

            (5,438)                                -   

8,616 

(5,438) 

            (5,438)                                 0                                -                                  -                                  -                                  -   

Net finance income or expenses from insurance contracts issued (F)

              3,076                                 1                               68                              14                               20                             102 

              3,179                                -   

3,179 

Total changes in the statement of profit or loss and in OCI (G=E+F) 

               (222)                               10                          (574)                              86                         2,156                        1,667 

              1,455                      (4,654) 

             16,756                       40,805 

           (19,022)                   (25,880) 

(3,199) 

57,561  (44,902) 

Premiums received 

Claims and other insurance service expenses paid

             16,756                                -                                  -                                  -                                  -                                  -   

           (19,022)                                -                                  -                                  -                                  -   

-   

Insurance acquisition cash flows paid

            (1,671)                                -                                  -                                  -                                  -   

-   

            (1,671)                      (5,812) 

(7,483) 

Total cash flows (H)

            (3,937)                                -                                  -                                  -                                  -   

-   

            (3,937)                         9,113 

5,176 

Effect of movements in exchange rates (I)

            (3,106)                            (28)                          (332)                           (22)                          (374) 

(728) 

            (3,862)                          (120) 

(3,982) 

Effect of changes in scope of consolidation and other changes (J)

                 523                                -                                  -                                  -                                  -   

-   

                 522                          (566) 

(46) 

Closing assets 

                (81)                                  1                                -                                  -                                71 

71 

                  (9)                                -   

(9) 

Closing liabilities 

           305,782                         1,420                         5,914                         2,550                      27,331 

35,795 

           342,997                    140,687 

483,684 

Net balance as of June 30 (K=A+G+H+I+J)

           305,702                         1,421                         5,914                         2,550                      27,402                       35,866 

           342,988                    140,687 

483,675 

(in Euro million) 

Analysis of changes occurred during the year 2023, restated, broken down by measurement component (only for non PAA contracts

)

 

Estimates of the PVFCF

 

RA

CSM

 

Carrying amount of non

PAA contracts

 

Carrying amount of PAA contracts

 

Total

Contracts measured at

transition under  the MRA

Contracts measured at

transition under  the FVA

Other contracts

Total 

CSM

Opening assets 

Opening liabilities 

(19) 

306,705 

                   -                                  -                                  -                                 15                              15 

                  (4)                                -   

           342,384                    131,987 

(4) 

474,371 

              1,350                        7,613                         2,610                       24,105 

34,328 

Net balance as of January 1 (A)

306,686 

              1,350                        7,613                         2,610                       24,120 

34,343 

           342,380                    131,987 

474,367 

CSM recognized in profit or loss for services provided 

-   

                   -                           (550)                          (240)                      (2,203) 

(2,992) 

            (2,992)                                -   

(2,992) 

Release of RA

-   

                (74)                                -                                  -                                  -   

-   

                (74)                                -   

(74) 

Experience adjustments 

(295) 

                    2                                -                                  -                                  -   

-   

               (293)                                -   

(293) 

Changes that relate to current services (B)

(295) 

                (72)                         (550)                          (240)                      (2,203) 

(2,992) 

            (3,360)                                -   

(3,360) 

Contracts initially recognized in the period  

(2,357) 

                  88                               57                                -                           2,233 

2,289 

                  20                                -   

20 

Changes in estimates that adjust the CSM

(1,886) 

                  97                               66                             180                         1,543 

1,789 

                  (0)                                -   

(0) 

Changes in estimates that result in losses and reversal of losses on onerous contracts 

26 

                    5                                -                                  -                                  -   

-   

                  31                                -   

31 

Changes that relate to future services (C)

(4,217) 

                 190                             123                             180                         3,776 

4,078 

                  52                                -   

52 

Adjustments to liabilities for incurred claims 

Changes that relate to past services (D)

(106) 

(106) 

                  (2)                                -                                  -                                  -   

                  (2)                                -                                  -                                  -   

-   

               (108)                                -   

               (108)                                -   

(108) 

(108) 

-   

Insurance service result (E=B+C+D)

(4,618) 

                 117                          (427)                            (60)                         1,573                         1,086 

            (3,416)                                -   

(3,416) 

Net finance income  or expenses recognized in profit or loss 

Net finance income  or expenses recognized in OCI

13,145  8,951 

                    0                              98                               18                               64                            180 

13,326               -    8,952     -   

13,326  8,952 

                    1                                -                                  -                                  -   

-   

Net finance income or expenses from insurance contracts issued (F)

22,096 

                    1                              98                               18                               64                            180 

             22,277                                -   

22,277 

Total changes in the statement of profit or loss and in OCI (G=E+F) 

17,478 

                 118                          (329)                            (42)                         1,637                         1,266 

             18,861                          (623) 

18,238 

Premiums received 

Claims and other insurance service expenses paid

31,672 

(38,572) 

                   -                                  -                                  -                                  -                                  -   

             31,672                       67,441 

           (38,572)                   (51,404) 

99,113 

(89,976) 

                   -                                  -                                  -                                  -   

-   

Insurance acquisition cash flows paid

(3,535) 

                   -                                  -                                  -                                  -   

-   

            (3,535)                    (10,025) 

(13,559) 

Total cash flows (H)

(10,435) 

                   -                                  -                                  -                                  -   

-   

           (10,435)                        6,013 

(4,422) 

Effect of movements in exchange rates (I)

(1,726) 

                (32)                         (464)                            (93)                          (165) 

(723) 

            (2,481)                          (578) 

(3,058) 

Effect of changes in scope of consolidation and other changes (J)

441 

                    3                                -                                 12                               28 

41 

                 485                             119 

604 

Closing assets 

(73) 

                    1                                -                                  -                                 59 

59 

                (13)                                -   

(13) 

Closing liabilities 

312,518 

              1,438                        6,820                         2,487                       25,560 

34,868 

           348,824                    136,915 

485,739 

Net balance as of December 31 (K=A+G+H+I+J)

312,444 

              1,439                        6,820                         2,487                       25,620                      34,927 

           348,810                    136,915 

485,726 

         7.3              MOVEMENTS IN BALANCES OF REINSURANCE CONTRACTS HELD

image

7.3.1 Changes in the carrying amount of reinsurance contracts held, split between remaining coverage and incurred claims components The two following tables provide an analysis of movements in the carrying amount of reinsurance contracts held split between the ARC and the AIC.

 

(in Euro million) 

Analysis of changes occurred during the first semester of 2024, split between ARC and AIC

ARC

AIC

 

 

 

 

Total

ARC

 

AIC related to PAA contracts

 

 

Excluding loss

recovery component

Loss recovery component

AIC related to non PAA contracts

Estimates of the PVFCF

RA

Total

Total AIC

Total 

Opening assets 

Opening liabilities 

12,560 

(7) 

(42) 

12,518 

(7) 

114 

-   

        22,395                       361                  22,756 

22,869 

-   

35,387 

(7) 

-   

              -                                -   

-   

Net balance as of January 1 (A)

12,553 

(42) 

12,511 

114 

       22,395                        361 

22,756 

22,869 

35,380 

Expenses from reinsurance contracts 

(5,709) 

-   

(5,709) 

-   

              -                                -   

-   

-   

(5,709) 

Changes in estimates that relate to losses and reversal of losses on underlying onerous contracts 

-   

34 

34 

-   

              -                                -   

-   

-   

34 

Amounts recovered from the reinsurers TUV

-   

(2) 

(2) 

339 

         3,065                       (22) 

3,043 

3,382 

3,380 

Net expenses from reinsurance contracts held (B)

(5,709) 

32 

(5,678) 

339 

         3,065                       (22) 

3,043 

3,382 

(2,296) 

Investment component  (C)

(821) 

-   

(821) 

821 

              -                                -   

-   

821 

-   

Net finance income or expenses recognized in profit or loss 

346 

346 

            358                             1 

359 

360 

706 

Net finance income or expenses recognized in OCI

(246) 

-   

(246) 

          (145)                             0 

(145) 

(144) 

(391) 

Net finance income or expenses from reinsurance contracts  held (D)

100 

100 

           214                             1 

215 

215 

316 

Effect of changes in the risk of non-performance by the reinsurers (E)

(4) 

-   

(4) 

(0) 

             20                              -   

20 

20 

17 

Total changes in the statement of profit or loss and in OCI (F=B+C+D+E)

(6,434) 

32 

(6,402) 

1,161 

         3,299                      (21)                     3,278 

4,438 

(1,963) 

Premiums paid (net of commissions related to premiums) 

Amounts received (net of commissions related to claims) 

18,382 

-   

-   

18,382 

-   

-   

(1,152) 

              -                             -                                -   

-   

(5,462) 

18,382 

(5,462) 

-   

       (4,310)                              -   

(4,310) 

Total cash flows (G)

18,382 

-   

18,382 

(1,152) 

       (4,310)                               -   

(4,310) 

(5,462) 

12,921 

Effect of movements in exchange rates (H)

207 

(1) 

206 

(0) 

           364                             5 

370 

369 

575 

Effect of changes in scope of consolidation and other changes (I)

65 

65 

(63) 

           (30)                             1 

(29) 

(92) 

(27) 

Closing assets 

24,781 

(11) 

24,770 

60 

        21,718                        346 

22,064 

22,124 

46,894 

Closing liabilities 

(8) 

-   

(8) 

-   

              -                                -   

-   

0   

(8) 

Net balance as of June 30 (J=A+F+G+H+I)

24,774 

(11) 

24,763 

60 

       21,718                       346                   22,064 

22,123 

46,886 

(a) Excl. effect of changes in the risk of non-performance by the reinsurers

 

 

(in Euro million) 

Analysis of changes occurred during the year 2023, restated, split between ARC and AIC

ARC

AIC

 

 

Total 

 

Excluding loss

recovery component

 

Loss recovery component

 

Total

ARC

 

AIC related to non PAA contracts

AIC related to PAA contracts

 

Total AIC

Estimates of the PVFCF

RA

Total

Opening assets 

Opening liabilities 

Net balance as of January 1 (A)

10,970 

(5) 

10,965 

240 

-   

11,210 

             79                 21,624                       378                  22,002 

22,081 

-   

22,081 

33,291 

(5) 

33,285 

(5) 

-   

79 

              -                            -                             -   

240 

11,205 

       21,624                        378 

22,002 

Expenses from reinsurance contracts 

(11,557) 

-   

(11,557) 

-   

              -                            -   

-   

-   

(11,557) 

Changes in estimates that relate to losses and reversal of losses on underlying onerous contracts 

-   

(5) 

(5) 

-   

              -                            -   

-   

-   

(5) 

Amounts recovered from the reinsurers TUV

-   

(6) 

(6) 

608 

         8,685                             0 

8,685 

9,293 

9,287 

Net expenses from reinsurance contracts held (B)

(11,557) 

(10) 

(11,567) 

608 

         8,685                             0 

8,685 

9,293 

(2,274) 

Investment component  (C)

Net finance income or expenses recognized in profit or loss 

Net finance income or expenses recognized in OCI

Net finance income or expenses from reinsurance contracts  held (D)

Effect of changes in the risk of non-performance by the reinsurers (E)

(433) 

71 

385 

456 

-   

(433) 

433 

(0) 

              -                            -   

            233                             3 

            682                             0 

           915                             3 

             (4)                          -   

-   

433  236 

-   

308 

72 

236 

-   

385 

682 

682 

918 

(4) 

1,067 

1,375 

(3) 

456 

-   

918 

-   

(4) 

Total changes in the statement of profit or loss and in OCI (F=B+C+D+E)

(11,533) 

(10) 

(11,544) 

         1,041                   9,597                            3                    9,600 

10,641 

(903) 

Premiums paid (net of commissions related to premiums) 

Amounts received (net of commissions related to claims)  Total cash flows (G)

13,388 

-   

13,388 

-   

-   

13,388 

              -                            -                            -                             -   

-   

(9,365)  (9,365) 

13,388 

(9,365)  4,023 

-   

(1,051) 

(1,051) 

       (8,314)                           -                   (8,314) 

-   

13,388 

       (8,314)                           -   

(8,314) 

Effect of movements in exchange rates (H)

(232) 

(228) 

(18) 

         (537)                        (21) 

(558) 

(576) 

(804) 

Effect of changes in scope of consolidation and other changes (I) Closing assets 

(34) 

12,560 

(277) 

(311) 

62 

114 

             25                             1 

        22,395                        361 

26 

89 

22,869 

(222) 

35,387 

(42) 

12,518 

22,756 

Closing liabilities 

(7) 

-   

(7) 

-   

              -                            -                             -   

-   

(7) 

Net balance as of December 31 (J=A+F+G+H+I)

12,553 

(42) 

12,511 

           114                 22,395                       361                  22,756 

22,869 

35,380 

(a) Excl. effect of changes in the risk of non-performance by the reinsurers

7.3.2 Changes in the carrying amount of reinsurance contracts held, broken down by measurement component

The two following tables provide an analysis of movements in the carrying amount of reinsurance contracts held, broken down by measurement component, namely (i) the estimate of PVFCF, (ii) the RA, and (iii) the CSM. However, the carrying amount of reinsurance contracts held measured under the PAA is also reported to reconcile with the opening and closing balances of financial statements

image

 

Analysis of changes occurred in the year 2023, restated, broken down by measurement component (only for non PAA contracts)

 

 

CSM

Carrying

 

 

(in Euro million) 

Estimates of the PVFCF

RA

Contracts measured at

transition under the MRA

Contracts measured at

transition under the FVA

Other contracts

Total 

CSM

amount

of non PAA contracts

Carrying amount of PAA contracts

TOTAL

Opening assets                                                                                                                                                        6,894                           127                            161                             392                              114 

               668                         7,689                      25,602                        33,291 

                  3                              (5)                                -                                  (5) 

Opening liabilities                                                                                                                                                         (8)                                0                                -                                     3 

-   

Net balance as of January 1 (A)                                                                                                                         6,886                           127                            161                              395 

114 

               670                         7,683                      25,602                        33,285 

CSM recognized for services received                                                                                                                      -                                 -                             (12)                              (46) 

(30) 

              (88)                            (88)                                -                               (88) 

Release of RA                                                                                                                                                                   -                             (10)                                -                                  -   

-   

                 -                             (10)                                -                               (10) 

Experience adjustments                                                                                                                                        (136)                                 0                                -                                  -   

-   

                 -                           (136)                                -                             (136) 

Changes that relate to current services (B)                                                                                                     (136)                           (10)                            (12)                             (46) 

(30) 

              (88)                          (234)                                -                             (234) 

Contracts initially recognized in the period                                                                                                        (15)                                 2                                -                                  -   

14 

                14                              (0)                                -                                  (0) 

Changes in estimates that adjust the CSM                                                                                                       (152)                              11                            101                                 28 

11 

               140                              (0)                                -                                  (0) 

Changes in estimates that relate to losses and reversal from losses on underlying

onerous contracts                                                                                                                                                        (7)                                1                                -                                  -   

-   

                 -                                (6)                                -                                  (6) 

Other changes in estimates that relate to future services                                                                             (67)                                -                                  -                                  -   

-   

                 -                             (67)                                -                               (67) 

Changes that relate to future services (C)                                                                                                       (241)                              14                            101                                 28 

25 

               154                            (73)                                -                               (73) 

Adjustments to assets for incurred claims                                                                                                            (3)                             (1)                                -                                  -   

-   

                 -                                (4)                                -                                  (4) 

Changes that relate to past services (D)                                                                                                               (3)                             (1)                                -                                  -   

-   

                 -                                (4)                                -                                  (4) 

Net expenses from reinsurance contracts held (E=B+C+D)                                                                        (381)                                 4                              89                           (19)                                (5) 

                66                         (311)                                -                             (311) 

Net finance income or expenses recognized in profit or loss                                                                           64                             (0)                                 2                                 5                                (0) 

                  6                              69                                -                                  69 

                 -                              385                                -                                385 

Net finance income or expenses recognized in OCI                                                                                          385                                 0                                -                                  -   

-   

Net finance income or expenses from reinsurance contracts held (F)                                                      448                              (0)                                 2                                 5                                (0) 

                  6                            454                                -                                454 

                 -                                   0                                -                                     0 

Effect of changes in the risk of non-performance by the reinsurers (G)                                                        0                               -                                  -                                  -   

-   

Total changes in the statement of profit or loss and in OCI (H=E+F+G)                                                       68                                4                              91                           (14)                                (5) 

                72                            143                      (1,046)                           (903) 

Premiums paid (net of commissions related to premiums)                                                                        2,687                               -                                  -                                  -                                  -   

-                           2,687         10,701           13,388 

-                           (1,051)      (8,314)          (9,365) 

Amount received (net of commissions related to claims)                                                                        (1,051)                                -                                  -                                  -   

-   

Total cash flows (I)                                                                                                                                                 1,636                               -                                  -                                  -   

-   

                 -                          1,636                        2,386                          4,023 

Effect of movements in exchange rates (J)                                                                                                      (143)                              (2)                           (10)                             (13) 

(8) 

              (31)                          (176)                         (627)                           (804) 

Effect of changes in scope of consolidation and other changes (K)                                                              (0)                               -                                  -                                  -   

28 

                28                              28                         (250)                           (222) 

Closing Assets                                                                                                                                                          8,460                           128                            240                              364 

130 

               734                         9,322                      26,065                        35,387 

Closing Liabilities                                                                                                                                                        (13)                                 0                                 2                                   3 

(0) 

                  5                              (7)                                -                                  (7) 

Net balance as of December 31 (L=A+H+I+J+K)                                                                                            8,447                           128                            242                             368                              130 

               740                         9,315                      26,065                        35,380 


II

                 

                                                                             CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

7.4           INSURANCE REVENUE AND CSM

image

7.4.1 Insurance revenue

The comparative analysis of insurance revenue recognised in the period is as follows:

(in Euro million)

June 30,

2024

Total 

June 30, 2023

Total 

Amounts relating to changes in LRC

CSM recognized in profit or loss for services provided 

1,521  40 

1,523  33 

Release of RA

Release of expected incurred claims and other insurance service expenses 

5,738 

5,621 

Experience adjustments  

935 

(16)  759 

Recovery of insurance acquisition cash flows 

Insurance revenue arising from non PAA contracts

8,235 

7,921 

Insurance revenue arising from PAA contracts

34,052 

31,273 

Total insurance revenue 

42,288 

39,194 

 

7.4.2 CSM

As of June 30, 2024, the total amount of CSM net of reinsurance contracts held reported in the consolidated statement of financial position was €33,564 million (€34,187 million as of December 31, 2023, restated).

 

June 30, 2024

December 31, 2023, restated

(in Euro million)

CSM arising from insurance contracts and investment contracts with DPF (A1)

35,795 

34,868 

CSM arising from reinsurance contracts held (A2)

(4) 

(5) 

Amount of CSM reported on the liability side of the consolidated statement of financial position (A=A1+A2)

35,792 

34,862 

CSM arising from insurance contracts and investment contracts with DPF (B1)

(71) 

(59) 

CSM arising from reinsurance contracts held (B2)

2,298 

734 

Amount of CSM reported on the asset side of the consolidated statement of financial position (B=B1+B2)

2,228 

675 

Net totalled amount of CSM (C= A-B)

33,564  35,866 

34,187 

of which CSM arising from insurance contracts and investment contracts with DPF (C1=A1-B1)

34,927 

of which CSM arising from reinsurance contracts held (C2=A2-B2)

(2,302) 

(740) 

image                                                              Half Year 2024 Financial Report                                                                           77

II

                 

                                                                             CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

7.5           DISCOUNT RATES

The estimates of future cash flows are discounted based on yield curves determined in a “risk-neutral” environment. The yield curves used as of June 30, 2024, December 31, 2023, and June 30, 2023, for the main currencies are disclosed in the tables below.

image

image

image                                                              Half Year 2024 Financial Report                                                                           78

II

                 

                                                                             CONSOLIDATED INTERIM FINANCIAL STATEMENTS – HALF YEAR 2024

The discount rates are based on swaps for most currencies and government bonds for others, adjusted by adding a liquidity premium net of credit risk adjustment. For the main currencies, these adjustments are disclosed in the table below:

Liquidity Premium, net of credit risk adjustment (in b

ps)

EUR

USD

GBP

June 30,  2024

December 31,  2023

June 30,  2023

June 30,  2024

December 31,                         June 30, 

               2023                           2023

June 30,  2024

December 31,  2023

June 30,  2023

23 

25 

26 

58 

                 65                                70 

39 

49 

45 

Liquidity Premium, net of credit risk adjustment (in b

ps)

JPY

CHF

HKD

June 30,  2024

December 31,  2023

June 30,  2023

June 30,  2024

December 31,                         June 30, 

               2023                           2023

June 30,  2024

December 31,  2023

June 30,  2023

(6)

(6)

(6)

-   

                   -                                     -   

10 

image                                                              Half Year 2024 Financial Report                                                                           79


NOTE 8 FINANCING DEBT

June 30, 2024

December 31, 2023

(in Euro million) 

Carrying value

Carrying value

AXA                                                                                                                                     

10,799

10,727

Subordinated green notes, 1.375%, due 2041 (in €)                                             

1,000

1,000

U.S. registered redeemable subordinated debt, 8.60% 2030 (euro)                 

908

891

Subordinated debt, 5.625%, due 2054 (£)                                                                

165

161

Subordinated debt, 3.375%, due 2047 (€)                                                                

1,500

1,500

Undated Subordinated notes, 850MUS$, 4.5%                                                       

793

769

Subordinated notes, 5.125%, due 2047 (USD)                                                        

933

905

AXA SA- Subordinated debt, 3.25%, due 2049 (€)                                                  

2,000

2,000

Subordinated Notes, 1,875% due 2042 (€)                                                               

1,250

1,250

Subordinated Notes, 4,25% due 2043 (€)                                                                 

1,250

1,250

Subordinated Notes, 5,5% due 2043 (€)                                                                   

1,000

1,000

AXA XL                                                                                                                                

230

223

Subordinated Notes, 5.5%, due March 2045 (USD)                                               

230

223

AXA Italy                                                                                                                            

66

66

Subordinated Notes, euribor 6 months + 81bp                                                      

66

66

Other subordinated debts (under €100 million)                                                   

4

4

Subordinated debt                                                                                                          

11,099

11,020

AXA                                                                                                                                     

2,850

2,100

Euro Medium Term Note, due through 2028                                                          

500

500

Euro Medium Term Note, due 2030                                                                           

850

850

Euro Medium Term Note, due 2033                                                                           

750

750

Senior Notes, May 31st, 2024 - €750M due 2034, 3.375%                                  

750

AXA XL                                                                                                                                

299

290

Senior Notes, 5.25%, due December 2043 (USD)                                                   

299

290

Other financing debts instruments issued (under €100 million)                      

78

21

Financing debt instruments issued                                                                            

3,227

2,411

TOTAL FINANCING DEBT                                                                                               

14,326

13,431

                                                                                         

image                                                                                       Half Year 2024 Financial Report                                                                             80

NOTE 9 FINANCIAL RESULT, EXCLUDING FINANCING DEBT EXPENSES

The financial result, excluding financing debt expenses, reflects the return on invested assets generated by all activities less the net finance income or expenses stemming from insurance and reinsurance contracts. The table below highlights how this financial result impacts both the profit or loss and the other comprehensive income (OCI) before tax.

The investment return through profit or loss reported below reconciles with the amount disclosed in the consolidated statement of profit or loss. On the other hand, the reconciliation of net finance income or expenses from insurance and reinsurance contracts disclosed below is presented in Note 7.1.2.

(in Euro million) 

June 30, 2024

 

Insurance

Other Activities

Total

Net investment income

of which interest revenue calculated using the effective interest method for financial assets measured at amortized cost of which interest revenue calculated using the effective interest method for financial assets measured at FV OCI

Net realized gains and losses relating to investments at amortised cost and at fair value through OCI of which net realized gains or losses relating to financial assets measured at amortized cost

of which net realized gains or losses relating to debt instruments measured at FV OCI (the amount reclassified upon derecognition from accumulated other comprehensive income to profit or loss for the period)

Net realized gains and losses and change in fair value of other investments at fair value through profit or loss 

Change in impairment on investments

6,340 

86 

57 

(40)

6,426 

464 

4,766 

423 

(0) 228 

456 

4,709 

464 

(0)

0  1 

(22)

(7)

227 

4,345 

4,322 

(211) 10,960 

(204)

 Investment return through profit or loss (A) 

10,944 

16 

Time value of money including interest accreted on Contractual Service Margin

Effect of changes in discount rates and other financial assumptions TUV

Change in fair value of underlying items of insurance contracts with direct participation features TbV

Foreign exchange gains or losses 

Other impacts 

(1,743)

-

-

(1,743)

73 

(7,920)

(183)

(97) (9,871)

73 

(7,920)

-

(183)

-

-

-   

(97)

 Net finance income or expenses from insurance contracts issued, through profit or loss (B) 

(9,871)

Time value of money including interest accreted on Contractual Service Margin

Effect of changes in discount rates and other financial assumptions 

Effect of changes in the risk of non-performance by reinsurers 

Foreign exchange gains or losses 

Other impacts 

448 

-

-

-

-

-

-   

448 

245 

245  17 

22 

(8)

17 

22 

(8)

 Net finance income or expenses from reinsurance contracts held, through profit or loss (C) 

723 

723 

 Total net finance income or expenses from insurance contracts issued and reinsurance contracts held, through profit or loss (D=B+C) 

(9,148)

-   

(9,148)

 Financial result recognized in profit or loss (E=A+D) 

1,795 

16 

1,812 

Realised capital gains or losses on equity instruments measured at fair value through OCI, without recycling in profit or loss 

Changes in fair value of financial investments through OCI TUV

199 

(1)

(112) (113)

198 

(7,594) (7,397)

(7,483)

 Investment return through OCI (F) 

(7,284)

Net finance income or expenses from insurance contracts issued through OCI (G) (b)

of which changes in fair value of underlying items of insurance contracts with direct participation features  of which realised capital gains or losses on equity instruments measured at fair value through OCI, without recycling in profit or loss

Net finance income or expenses from reinsurance contracts held through OCI (H)

6,278 

-

6,278 

3,308 

(21)

(391) 5,888 

3,308 

-

-

(21)

(391)

-

-   

 Total net finance income or expenses from insurance contracts issued and reinsurance contracts held through OCI (I=G+H) 

5,888 

 Financial result recognized in OCI (J=F+I) 

(1,396)

(113)

(1,509)

 Impact of financial result on the statement of comprehensive income (before tax) (K=E+J) 

399 

(96)

303 

(a) Including both the change in fair value with recycling in profit or loss and the change in fair value without recycling in profit or loss. ( b) The effect of the risk mitigation option is included in P&L for €114m and in OCI for €579m, respectively.

          image                                                                  Half Year 2024 Financial Report                                                                 ǝǖ

                                                                                                                                                                                                                                                           June 30, 2023

Other

(in Euro million) 

Insurance

Activities

Total

Net investment income

5,191 

358 

5,549 

of which interest revenue calculated using the effective interest method for financial assets measured at amortized cost

391 

397 

of which interest revenue calculated using the effective interest method for financial assets measured at FV OCI

4,355 

54 

4,409 

Net realized gains and losses relating to investments at amortised cost and at fair value through OCI

(1,286)

(14)

(1,300)

of which net realized gains or losses relating to financial assets measured at amortized cost

(2)

(2)

of which net realized gains or losses relating to debt instruments measured at FV OCI (the amount reclassified upon derecognition from accumulated other comprehensive income to profit or loss for the period)

(1,426)

(12)

(1,438)

Net realized gains and losses and change in fair value of other investments at fair value through profit or loss 

4,563 

(31)

4,532 

Change in impairment on investments

(155)

(6)

(161)

 Investment return through profit or loss (A) 

8,314 

307 

8,620 

Time value of money including interest accreted on Contractual Service Margin

(1,342)

-

(1,342)

Effect of changes in discount rates and other financial assumptions TUV

293 

-

293 

Change in fair value of underlying items of insurance contracts with direct participation features TbV

(6,407)

-

(6,407)

Foreign exchange gains or losses 

171 

-

171 

Other impacts 

(248)

-

(248)

 Net finance income or expenses from insurance contracts issued, through profit or loss (B) 

(7,533)

-

(7,533)

Time value of money including interest accreted on Contractual Service Margin

241 

-

241 

Effect of changes in discount rates and other financial assumptions 

(33)

-

(33)

Effect of changes in the risk of non-performance by reinsurers 

(6)

-

(6)

Foreign exchange gains or losses 

(49)

-

(49)

Other impacts 

(1)

-

(1)

 Net finance income or expenses from reinsurance contracts held, through profit or loss (C) 

153 

-

153 

 Total net finance income or expenses from insurance contracts issued and reinsurance contracts held, through profit or loss (D=B+C) 

(7,380)

-

(7,380)

 

 

 

 

 Financial result recognized in profit or loss (E=A+D) 

933 

307 

1,240 

Realised capital gains or losses on equity instruments measured at fair value through OCI, without recycling in profit or loss 

183 

(64)

120 

Changes in fair value of financial investments through OCI TUV

7,163 

30 

7,193 

 Investment return through OCI (F) 

7,346 

(34)

7,312 

Net finance income or expenses from insurance contracts issued through OCI (G) (b)

(6,213)

-

(6,213)

of which changes in fair value of underlying items of insurance contracts with direct participation features 

(353)

-

(353)

of which realised capital gains or losses on equity instruments measured at fair value through OCI, without recycling in profit or loss

(83)

-

(83)

Net finance income or expenses from reinsurance contracts held through OCI (H)

420 

-

420 

 Total net finance income or expenses from insurance contracts issued and reinsurance contracts held through OCI (I=G+H) 

(5,792)

-

(5,792)

 Financial result recognized in OCI (J=F+I) 

1,554 

(34)

1,520 

 Impact of financial result on the statement of comprehensive income (before tax) (K=E+J) 

2,487 

273 

2,760 

(a) Including both the change in fair value with recycling in profit or loss and the change in fair value without recycling in profit or loss.

(b) The effect of the risk mitigation option is included in P&L for €314m and in OCI for €629m, respectively.

                                                                                                                                                                                                                 82


NOTE 10 NET INCOME PER ORDINARY SHARE

The Group calculates a basic net income per ordinary share and a diluted net income per ordinary share:

•       the calculation of the basic net income per ordinary share assumes no dilution and is based on the weighted average number of outstanding ordinary shares during the period;

•       the calculation of diluted net income per ordinary share takes into account shares that may be issued as a result of stock option and share based compensation plans. The effect of stock option and share based compensation plans on the number of fully diluted shares is taken into account only if options and share based compensations are considered to be exercisable on the basis of the average stock price of the AXA share over the period.

(in Euro Million) QRS

 

June 30, 2024

June 30, 2023

NET INCOME GROUP SHARE

 

4,020 

3,833 

Undated subordinated debt financial charge

(106)

(92)

NET INCOME INCLUDING IMPACT OF UNDATED SUBORDINATED DEBT

A

3,914 

3,741 

Weighted average number of ordinary shares (net of treasury shares) - opening

Increase in capital (excluding stock options exercised)

Stock options exercised TWV Treasury shares TWV

Capital increase/Decrease TWV

2,226 

2,265 

-

34 

(59)

-

(18)

-

WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES

B

2,209 

2,241 

BASIC NET INCOME PER ORDINARY SHARE

C = A / B

1.77 

1.67 

Stock options

Other

FULLY DILUTED - WEIGHTED AVERAGE NUMBER OF SHARES PZR

D

2,215 

2,247 

FULLY DILUTED NET INCOME PER ORDINARY SHARE

E = A / D

1.77 

1.67 

(a) Except for number of shares (million of units) and earnings per share (Euro).

(b) Weighted average.

(c) Taking into account the impact of potentially dilutive impacts

                                                                                                                                                                                                       83

NOTE 11 SUBSEQUENT EVENTS

AXA entered into an exclusive negotiation to sell AXA Investment Managers to BNP Paribas On August 1, 2024, AXA announced that it has entered into an exclusive negotiation to sell its asset manager AXA Investment Managers (“AXA IM”) to BNP Paribas for cash proceeds(1) of €5.1 billion. In addition, AXA would receive €0.3 billion consideration from the sale of Select(2) to AXA IM prior to the closing of the proposed transaction. The total estimated transaction value is expected to be €5.4 billion, representing a multiple of 15x 2023 earnings. Under the terms of the proposed transaction, AXA and BNP Paribas would also enter into a long-term strategic partnership under which BNP Paribas would provide investment management services to AXA. The combination of AXA Investment Managers and BNP Paribas would create a leading European asset manager, with total assets under management of €1.5 trillion(3)

The intention to exit the Asset Management business further emphasizes the Group’s strategy to simplify its business model and to focus on its core insurance activities. In particular, AXA’s Life & Savings business is wellpositioned to grow, driven by the Group’s strong distribution and product design capabilities, and our customers will benefit from a broader array of asset classes, including continued access to a best-in-class Alternatives asset management platform. AXA retains full authority over product design, asset allocation and asset-liability management decisions. 

The completion of the transaction is subject to customary closing conditions, including the information and consultation of employee representative bodies, followed by the signing of the Share Purchase Agreement and the receipt of regulatory approvals, and is expected to be finalized by the second quarter of 2025. 

Starting from FY24, AXA IM will be classified as ‘discontinued operations’ in AXA’s consolidated financial statements and AXA will continue to account for the contribution of AXA IM to the Group’s Underlying Earnings until the expected completion of the sale. Upon completion, the proposed transaction is expected to result in (i) a reduction in Underlying Earnings of ca. Euro 0.4 billion on an annualized basis for the Group and (ii) an estimated one-off Net Income gain of €2.2 billion. AXA intends to offset the earnings dilution from the proposed disposal with a share buyback, currently estimated at Euro 3.8 billion, to be launched immediately following the closing of the proposed transaction. The proposed transaction and the associated share buyback are expected to have a neutral impact on AXA’s Solvency II ratio. The proposed transaction is expected to have no material impact on the key financial targets(4 that were communicated as part of the ‘Unlock the Future’ plan.

image 

(1) For 100% share capital of AXA IM, of which 98% is owned by the AXA Group (67% by AXA SA and 31% by other AXA entities), subject to price adjustment mechanisms.

(2) Select (formerly named ‘Architas’) is an AXA company offering investment solutions, including management of funds, investment management services, advisory services and investment related services, to retail customers in France, Belgium, Hong Kong and Indonesia.

(3) As of December 31st, 2023, based on companies’ financial disclosures.

(4) Underlying earnings per share CAGR 2023-2026E between 6% and 8%, Underlying return on equity between 14% and 16% over 2024E to 2026E, over Euro 21 billion cumulative organic cash upstream over 2024E to 2026E.

                                                                                                                                                                                                       84

 

III. Statutory auditors’ review report 

 /

 

on the 2024 Half Year Financial Information

 

 

 

 

 

 

 

 

AXA SA 

Statutory Auditors' Review Report  on the half-year Financial Information

 

(Period from January 1st to June 30th 2024) 


ERNST & YOUNG Audit

Tour First

TSA 14444

92037 Paris-La Défense cedex

S.A.S. à capital variable

344 366 315 R.C.S. Nanterre

Commissaire aux Comptes Membre de la compagnie régionale de Versailles et du Centre KPMG S.A.

Tour Eqho

2, avenue Gambetta

CS 60055

92066 Paris La Défense cedex

Commissaire aux Comptes Membre de la compagnie régionale de Versailles et du Centre


Statutory Auditors’ Review Report on the half-year Financial Information

 

(Period from January 1st to June 30th, 2024)

To the Shareholders, AXA SA

25, avenue Matignon

75008 Paris

In compliance with the assignment entrusted to us by your Shareholders’ Meetings and in accordance with the requirements of Article L. 451-1-2-III of the French Monetary and Financial Code (Code monétaire et financier), we hereby report to you on:

§  the review of the accompanying condensed half-year consolidated financial statements of AXA SA, for the period from January 1st to June 30th, 2024;

§  the verification of the information presented in the half-year management report.

These condensed half-year consolidated financial statements are the responsibility of the Board of Directors. Our role is to express a conclusion on these financial statements based on our review.

1.  Conclusion on the financial statements

We conducted our review in accordance with professional standards applicable in France. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with professional standards applicable in France and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Based on our review, nothing has come to our attention that causes us to believe that the condensed half-year consolidated financial statements are not prepared, in all material respects, in accordance with IAS 34, standard of the IFRSs as adopted by the European Union applicable to interim financial information.

2.  Specific verification

We have also verified the information presented in the half-year management report on the condensed half-year consolidated financial statements subject of our review. 

We have no matters to report as to its fair presentation and consistency with the condensed half-year consolidated financial statements. It is not our responsibility to conclude on the fair presentation and consistency with the halfyear financial statements of the solvency related information. 

Paris-La Défense, August 1st, 2024

The Statutory Auditors

French original signed by*

 

                                 ERNST & YOUNG Audit                                                                                  KPMG S.A.

    Olivier Durand             Patrick Menard                                           Pierre Planchon      Antoine Esquieu

 

*This is a translation into English of the statutory auditors’ review report on the half-year financial information issued in French and is provided solely for the convenience of English-speaking users. This report should be read in conjunction with, and construed in accordance with, French law and professional standards applicable in France.


 

     IV. Statement of the person             responsible 

     /

  

       for the Half Year

       Financial Report

 

   STATEMENT OF THE PERSON RESPONSIBLE FOR THE HALF YEAR REPORT

 

 

 

 

Statement of the person responsible for the Half-Year Financial Report  

I certify, to the best of my knowledge, that the consolidated interim financial statements for the past half-year have been prepared in accordance with applicable accounting standards and give a fair view of the assets, liabilities and financial position and profit or loss of the Company and all the undertakings included in the consolidation, and that the interim management report, to be found in the first part of this Report, presents a fair review of the important events that have occurred during the first six months of the financial year, their impact on the financial statements, major related-party transactions, and describes the principal risks and uncertainties for the remaining six months of the financial year. 

Paris, August 1st, 2024.

IV

Thomas Buberl

Chief Executive Officer

  

image                                                                               Half Year 2024 Financial Report                                                                                   90

See all AXA news